Motion sickness

Douglas J Lanska MD MS MSPH

Neuro-Ophthalmology & Neuro-Otology

Updated 05.14.2024
Released 09.10.2009
Expires For CME 05.14.2027

Motion sickness

Author: Douglas J Lanska MD MS MSPH

See Contributor Disclosures

Motion sickness

In This Article

Quick Link

Introduction

Overview

In this article, the author explains the clinical presentation, pathophysiology, and management of motion sickness. Motion sickness is a normal response to complex motion stimuli of sufficient intensity and duration that is thought to be due to a mismatch of signals from vestibular, visual, and proprioceptive receptors as integrated in the brainstem and cerebellum. Relevant vestibular physiology is reviewed, particularly concerning space sickness (space adaptation syndrome) and the vestibular experiments conducted in Skylab, Spacelab, Earth-orbiting Space Shuttle missions, and the International Space Station.

Key points

	• Motion sickness is a normal response to complex motion stimuli of sufficient intensity and duration.
	• Motion sickness typically occurs with unfamiliar motion to which an individual has not adapted.
	• Motion sickness can produce uncomfortable or unpleasant and sometimes incapacitating manifestations, but the most common include pallor, cold sweating (diaphoresis), anorexia, nausea, and vomiting.
	• The earliest symptom is typically epigastric discomfort (“stomach awareness”), followed by malaise and a feeling of warmth, often coincident with the onset of nausea. The development of pallor, diaphoresis, and changes in respiratory rhythm herald the onset of vomiting, which generally produces some temporary symptomatic improvement.
	• In some cases that do not reach the threshold of vomiting, manifestations may be limited to fatigue and drowsiness, ie, the “sopite syndrome.”
	• Susceptibility to motion sickness varies with age (with peak prevalence between ages 4 and 12 years), gender (women more often affected, especially during menstruation, in most studies). Other risk factors include a history of motion sickness, a history of migraine headaches, family history of motion sickness, and Asian heritage.
	• Motion sickness is thought to be due to a mismatch of signals from vestibular, visual, and proprioceptive receptors as integrated in the brainstem and cerebellum.
	• Motion sickness is distinct from mal de debarquement because subjects with motion sickness experience symptoms during the period of motion and briefly afterwards, whereas mal de debarquement subjects experience symptoms following termination of motion. Furthermore, subjects with mal de debarquement do not commonly have associated nausea, vomiting, diaphoresis, or headache, all of which are common with motion sickness.
	• To minimize visual-vestibular mismatch, it helps to be able to have correct visual cues for orientation; therefore, it helps to direct attention to a stable orientational reference (eg, looking at the horizon while aboard ship or looking out through the windshield at a distant point ahead while a passenger in the front seat of a car as opposed to looking out a side window from the back seat or, worse, trying to read), to avoid enclosed cabins, and to avoid focusing on nearby objects (eg, waves, other vehicles) and, especially, tasks involving visual search of nearby objects (eg, reading or map reading).
	• Transdermal scopolamine (l-hyoscine) is probably the most effective available medication for prevention of motion sickness.

Historical note and terminology

Motion sickness, or kinetosis, is a normal response to complex motion stimuli of sufficient intensity and duration. It typically occurs with unfamiliar motion to which an individual has not adapted. Motion sickness can produce uncomfortable or unpleasant and sometimes incapacitating manifestations, but the most common include pallor, cold sweating (diaphoresis), anorexia, nausea, and vomiting. There is a wide range of susceptibility to motion sickness as well as considerable variability in the relative prominence of the clinical manifestations, but all healthy unmedicated individuals can become motion sick with sufficient provocative stimuli (128).

Motion sickness may have evolved as a negative reinforcement system designed to terminate motion involving sensory conflict or postural instability that would have impaired evolutionary fitness via injury or signaling weakness and vulnerability to predators (24; 128). Such a negative reinforcement mechanism would have functioned much like pain to strongly motivate behavior-preserving evolutionary fitness. Alternate theories positing that motion sickness facilitated the avoidance or elimination of neurotoxins cannot account for the rarity of motion sickness in infants and toddlers.

Motion sickness has been recognized for centuries, especially in the form of seasickness (83). Hippocrates wrote on sea sickness (176). Indeed, the etymology of the English word nausea is from the Greek word naus, meaning ship, or nautēs, meaning sailor. As expressed by Hill:

Ever since the first Palaeolithic man ventured afloat in a hollow tree-trunk, Homo sapiens has been striving to adapt his reflexes to movement in three planes. But his sapient mind travels with more ease and comfort in four dimensions than his human body does in three. …It is as natural for the novice to be sea-sick in stormy weather as for the toddler to stumble or the inexpert golfer to foozle his drive (74).

Medieval carving of Saint David, sea-sick during his journey to the holy land

Medieval carving of Saint David, sea-sick during his journey to the holy land, as depicted on a misericord in Saint David's Cathedral in the county of Pembrokeshire, near the most westerly point of Wales. A misericord (or mercy...

Chinese medical classics recognized the particular susceptibility of children to motion sickness and distinguished several forms of travel sickness (26; 83). By 300 A.D., the Chinese recognized cart sickness, experienced by persons traveling in arid northern China, as distinct from sea sickness, experienced by persons traveling by boat in southern China, where rivers were important for transportation. In the Middle Ages, a third form of motion sickness was recognized: litter sickness, experienced by persons transported in a bed suspended between two long poles.

On November 16, 1809, in his Croonian Lecture to the Royal Society, English chemist and physicist William Hyde Wollaston (1766-1828) attributed motion sickness to motion-induced fluctuations in the pressure within cerebral blood vessels (193; 104):

English chemist and physicist William Hyde Wollaston (1766–1828)

Painting by John Jackson (1778-1831). (Courtesy of Wikipedia. Contributed by Dr. Douglas J Lanska.)

If a person be supposed standing erect upon deck [of a ship], it is evident that the brain, which is uppermost, then sustains no pressure from the mere weight of the blood, and that the vessels of the feet and lower parts of the body must contract, with a force sufficient to resist the pressure of a column of blood, of between five and six feet from the head downwards. If the deck were by any means, suddenly and entirely removed, the blood would be no longer supported by its vessels; but both would wall together with the same velocity by the free action of gravity; and the same contraction of the vessels which before supported the weight of the blood would now occasion it to press upon the brain, with a force proportional to its former altitude. In the same manner, and for the same reason, during a more gradual subsidence of the deck, and partial removal of support, there must be a partial diminution of the pressure of the blood upon its vessels, and consequently, a partial reaction upon the brain, which would be directly counteracted by a full inspiration. … The sickness occasioned by swinging is evidently from the same causes as sea-sickness, and that direction of the motion which occasions the most piercing sensation of uneasiness, is conformable to the explanation above given (193).

In 1881, Irish-American physician John Arthur Irwin (1853-1912) suggested that sensory conflict was the principle etiologic factor in the development of seasickness, or more generally in what he labeled “motion sickness” (85; 03; 105). Irwin recognized that the “’faculty of equilibrium’ appears to be more of less connected with the cerebellum, the optic lobes, and possibly with other parts of the nervous organization, but beyond doubt its principal seat is in the semicircular canals of the internal ear, which may for practical purposes be regarded as ‘the organs of equilibrium.’”

Irish-American physician John Arthur Irwin (1853-1912)

Source: Anonymous. Irwin, John Arthur. In: The national cyclopaedia of American biography: being the history of the United States as illustrated in the lives of the founders, builders, and defenders of the Republic, and of the ...

In 1882, American philosopher and psychologist William James (1842-1910) supported this concept when he reported that deaf-mutes were resistant to the development of seasickness, providing further evidence that the vestibular apparatus was somehow involved in the pathophysiology of this condition (87; 105).

William James (1842-1910)

American psychologist and philosopher William James (1842-1910) found that deaf-mutes were resistant to the development of seasickness. (Courtesy of the U.S. National Library of Medicine. Contributed by Dr. Douglas J Lanska.)

Many other means of conveyance besides boats and ships, and later other motion stimuli (eg, visual optokinetic stimuli and 3-D movies), were linked with the development of motion sickness; in many cases, each was given its own name (35; 145; 79; 80; 130; 137; 31; 23; 30; 55; 164; 26; 29). Such subcategories of motion sickness include, for example, cart sickness, litter sickness, airsickness, car sickness, camel sickness, cyber sickness (virtual reality), elevator sickness, simulator sickness, ski sickness, space sickness, swing sickness, train sickness, and motorist's disorientation syndrome (142; 72; 14; 30; 34; 18; 147; 152; 29).

Motion sickness affects about one third of zero-g fliers (57), and 50% to 70% of all space travelers during the first 24 to 72 hours of a spaceflight (177; 152).

Historical aspects of the prevention and treatment of motion sickness. Despite centuries of interest in the condition, prevention and management of motion sickness have been and remain less than ideal (56). In a news item in the 1881 Pacific Medical and Surgical Journal the treatment of seasickness by different prominent neurologists of the time was summarized, based on a report in the New York Medical Record and additional commentary:

Several physicians have been interviewed by newspaper reports on the subject of seasickness. Dr. Alonzo Clark recommends a wash-bowl, Dr. [George Miller] Beard bromization, and Dr. [William Alexander] Hammond chloroform and bromides. The editors comment upon the uncertainties of medicine and the disagreement of doctors. Without entirely disregarding bromides, we think highly of the washbowl… When the senior editor shipped at New York for California thirty-one years ago, he observed in his state-room a tin vessel with hooks for handles, the use of which at first was a great puzzle; but in the course of time he found it much more convenient than a wash-bowl (04).

Belladonna alkaloids were also found empirically to be beneficial, but as cautioned by Hill: “there is no panacea to be found in ‘all the drowsy syrups of the world,’ or even all the alkaloids of belladonna” (74).

Clinical manifestations

Presentation and course

	• The most characteristic symptoms of motion sickness are pallor, nausea, and vomiting, with vomiting taking prominence in many studies (especially early drug trials) as an essential feature because it is unambiguous, as is the time from onset of provocative motion to onset of vomiting.
	• Motion sickness is associated with prominent vegetative disturbances, particularly involving the gastrointestinal and cardiovascular systems.
	• The earliest symptom of motion sickness is typically epigastric discomfort (“stomach awareness”), followed by malaise and a feeling of warmth, often coincident with the onset of nausea.
	• In some cases of motion sickness that do not reach the threshold of vomiting, manifestations may be limited to fatigue and drowsiness, a situation that has been termed the “sopite syndrome”.
	• Susceptibility to motion sickness varies with age, being rare in infants and toddlers below 2 years of age, rising to a peak prevalence between the ages of 4 and 12 years, and then progressively declining.
	• Risk factors for motion sickness include a history of motion sickness, a history of migraine headaches, menstruation, pregnancy, family history of motion sickness, and Asian heritage.

The most characteristic symptoms of motion sickness are pallor, nausea, and vomiting, with vomiting taking prominence in many studies (especially early drug trials) as an essential feature because it is unambiguous, as is the time from onset of provocative motion to onset of vomiting. More recent studies have relied heavily on surrogate electrophysiological measurements (eg, with the electrogastrogram) or compound questionnaire-based scales.

More generally, motion sickness is associated with prominent vegetative disturbances, particularly involving the gastrointestinal and cardiovascular systems. Gastrointestinal symptoms include anorexia, epigastric discomfort, increased salivation, frequent swallowing, belching, borborygmi, nausea, and eventually vomiting. Cardiovascular manifestations can include facial pallor, clammy extremities, and in severe cases hypotension and a shock-like state. In addition, there may be headache (often frontal), vague dizziness, cold sweating (diaphoresis), tremor or tremulousness, mild hypothermia, and changes in respiratory rhythm (eg, sighing, yawning, and hyperventilation with alkalosis, perioral and acral paresthesias, and occasionally tetany and carpopedal spasms). Yawning has been suggested as a behavioral marker of the onset of soporific effects associated with motion sickness (120). Other symptoms include apathy, fatigue, depression, drowsiness, and exhaustion (126; 64; 14; 100; 120).

The earliest symptom of motion sickness is typically epigastric discomfort (“stomach awareness”), followed by malaise and a feeling of warmth, often coincident with the onset of nausea (14). The development of pallor, diaphoresis, and changes in respiratory rhythm herald the onset of vomiting. Vomiting generally produces some temporary symptomatic improvement (126), but continued exposure produces recurrent waves of nausea and ultimately vomiting or retching (if stomach contents have already been expelled).

In some cases of motion sickness that do not reach the threshold of vomiting, manifestations may be limited to fatigue and drowsiness, a situation that has been termed the “sopite syndrome” (64; 14; 100). Even when motion sickness and soporific symptoms are mild, multitasking cognitive performance declines (121).

Susceptibility to motion sickness varies with age, being rare in infants and toddlers below 2 years of age, rising to a peak prevalence between the ages of 4 and 12 years, and then progressively declining (126; 179; 49; 14; 128; 160; 73; 26; 57). In a cross-sectional study, about 40% of children aged 7 to 12 years report motion sickness when traveling in a car or bus (73).

Susceptibility also varies by gender, with women being more susceptible in most studies (126; 67; 68; 88; 137; 179; 160), particularly during menstruation (67; 68); however, certain motion environments with highly selected samples show different patterns (eg, female astronauts are slightly less susceptible to space sickness than their male colleagues) (88; 137; 14), and women do not show greater tachygastria during exposure to optokinetic stimuli (88; 137).

Other risk factors for motion sickness include a history of motion sickness (79); a history of migraine headaches (102; 08; 06; 68; 160), particularly vestibular migraine (196; 123); menstruation (160); pregnancy (160); family history of motion sickness; and Asian heritage (169). Approximately one half to two thirds of migraineurs report motion sickness susceptibility (102; 08; 06; 161; 128). A quick way to determine motion sickness susceptibility in migraine patients is to ask, “Can you read while travelling in a car without getting motion sick?” (01). Risk factors for motion sickness in zero-g parabolic flights include younger age, and protective factors include prior zero-g flight experience (habituation), and antimotion sickness medication (57). Sleep deprivation may contribute to motion sickness incidence and severity and may also degrade the capacity to compensate for perturbed motion (91). Concussion symptoms significantly increase the risk and severity of visually induced motion sickness (97).

Levels of sickness reported in studies anticipating future increase in transportation using automated vehicles are relatively low in vehicles simulating automated vehicles (154). However, the frequency of motion sickness was significantly higher with rear-facing travel than with forward-facing travel, a difference that was particularly pronounced under urban driving conditions (154).

Prognosis and complications

Individual susceptibility to motion sickness varies greatly, as a function of receptivity, adaptability, and retention of adaptation (144). Receptivity reflects a higher intrinsic susceptibility to motion sickness, presumably as a result of a more intense mismatch signal. Adaptability reflects the speed of adjustment, with those adapting more slowly experiencing presumably a more prolonged mismatch signal and, as a result, a higher likelihood of developing motion sickness than rapid adaptors. Retentivity (retention of adaption) reflects how well protective adaptation from prior exposure is retained and able to be used on re-exposure to a provocative motion stimulus.

If the motion is continued for several days, motion sickness generally diminishes or subsides (126; 195). Active movement in the provocative motion environment may facilitate adaption, as long ago “summed up in the commons-sense axiom that one cannot expect to get one’s sea-legs by lying in bed” (74). Suppression of motion sickness with scopolamine slows the rate of adaptation, indicating that if the nervous system “is not challenged by disruption of normal activation, it does not produce the compensation reactions that result in habituation [adaptation]” (195). Some degree of adaptation to optokinetic rotation is retained for up to a year (81).

The terms “adaptation” and “habituation” have been variously used (126). The word “adaptation” has been used to indicate a decline in response to a provocative motion stimulus, the change in neural processes responsible for the decline in response, the process by which the responsible neural processes are modified, or in a general way to refer to all of these (126). Money has suggested that the term “adaptive change” be used to indicate the change in neural mechanisms responsible for a decline in response to provocative motion, the term “habituation” be used for the acquisition of this adaptive change, and the term “dishabituation” be used for the process of losing an adaptive change (126).

Motion sickness is a risk factor for postoperative vomiting in children (32).

Enhanced motion intolerance is also a characteristic of vestibular migraine, suggesting that in vestibular migraine there is a disruption of normal brain mechanisms that control central vestibular signals to minimize intravestibular sensory conflict (187).

Biological basis

	• Motion sickness results from a mismatch of signals from vestibular, visual, and proprioceptive receptors as integrated in the brainstem and cerebellum.
	• Sensory conflict is important in the development of motion sickness and more specifically, a conflict between incoming sensory information from position and motion senses and what is expected from prior experience.
	• The pathogenesis of motion sickness remains incompletely understood and several different pathogenetic models have been proposed.

Anatomic localization

Motion sickness results from a mismatch of signals from vestibular, visual, and proprioceptive receptors as integrated in the brainstem and cerebellum (143; 142; 134; 188; 175; 42; 161). Vestibular inputs are felt to be fundamental as deaf-mute individuals with bilateral vestibular hypofunction do not become seasick (87); other individuals with bilateral vestibular hypofunction and experimental animals after bilateral labyrinthectomy are similarly spared (165; 96; 126; 14). Visual influences alone can be provocative in susceptible patients (35; 145; 79; 80; 130; 137; 31; 23; 28; 20), but motion sickness can be elicited in blind individuals (61) or in sighted individuals in darkness or with eyes closed (14).

One group has proposed that motion sickness is mediated through the orientation properties of velocity storage in the vestibular system (42; 45; 46) and, specifically, that the nodulus and uvula of the vestibulocerebellum may be the location where sensory mismatch or disparity is assessed, and where habituation occurs (14; 42; 45), but this remains somewhat conjectural (14). Purkinje cells in the cerebellar flocculus have been identified that signal visual-vestibular disparity (115; 14). Furthermore, damage to the vestibulocerebellum impairs or precludes habituation to vestibular stimuli (192) and prevents adaptive modifications to the vestibulo-ocular reflex (150).

Vestibular nuclei have also been proposed as the location of the mismatch comparator (14); however, although second-order neurons in the vestibular nuclei have been identified that respond to visual (optokinetic) and proprioceptive (joint movement) stimuli, no neurons in the vestibular nuclei have been identified to date that signal sensory mismatch (14).

The pathways mediating autonomic nervous system involvement in motion sickness have been incompletely elucidated. Vomiting is mediated by a so-called “vomiting center,” a poorly localized area of the parvicellular reticular formation in the medulla, ventral to the vestibular nuclei and separate from the area postrema (22; 124; 21; 14).

Cerebral influences are not essential for development of the cardinal manifestations of motion sickness, as for example such manifestations can be elicited in experimental decerebrate animals in response to provocative motion stimuli (14); nevertheless the cerebral cortex is involved in the expression of some of the symptoms of motion sickness (eg, nausea, dizziness, somnolence, fatigue) and is involved in conditioned aversive responses to motion or to optokinetic stimuli (14; 55). Other factors can also augment the development of motion sickness, including for example afferent visceral impulses (eg, from movement of viscera distended by gas) and repulsive odors.

Pathophysiology

Sensory conflict. As early as 1881, Irwin suggested a role for sensory conflict in the development of motion sickness, and more specifically a conflict between incoming sensory information from position and motion senses and what is expected from prior experience:

In the visual vertigo of sea-sickness there appears to be a discord between the immediate or true visual impressions and a certain visual habit or visual sense of the fitness and order of things, which passes into consciousness as a distressing feeling of uncertainty, dizziness, and nausea. It seems possible that tactile impressions or feelings of indefinite motion conveyed through the feet in walking &c may also exercise some influence. [emphasis in original] (85).

"Sensory rearrangement theory” and “neural mismatch model.” Several authors (127) proposed similar ideas in the century after Irwin’s paper (85) until the synthesis by Reason and Brand in 1975 with their “sensory rearrangement theory” and “neural mismatch model” (143; 142), which utilized some of the concepts of Von Holst and others (185). In their sensory rearrangement theory, Reason and Brant suggested, based on prior information, that the vestibular system must be implicated directly or indirectly (as in visually induced motion sickness), and that provocative stimuli are characterized by “a condition of sensory rearrangement” (ie, learning) in which conflicting motion signals from the labyrinth, eyes, and proprioceptors (ie, new data) are different from “what is expected on the basis of previous transactions with the spatial environment” (existing knowledge). Once learning has occurred, the previously provocative stimulus no longer results in symptoms of motion sickness.

Two types of sensory rearrangement were emphasized: visual-vestibular (ie, a conflict between different sense modalities) and canal-otolith (ie, an intramodality conflict between different vestibular receptor systems). Examples of visual-vestibular conflict or mismatch include reading handheld material in a moving vehicle, making head movements with new glasses (with a changed lens prescription), and watching an IMAX movie. Examples of canal-otolith conflict or mismatch (in a patient with a normal vestibular system) include making head movements in one axis while rotating about another axis (so-called cross-coupled, or Coriolis, stimulation) (90), or making head movements in an atypical acceleration environment (eg, microgravity, or the hypergravity experienced by jet fighter pilots in tight turns). Canal-otolith conflicts are a major contributor to space sickness in astronauts: in weightless the semicircular canals continue to correctly transduce rotational acceleration of the head, but the otoliths provide different afferent information from that provided in a 1-g (terrestrial) environment.

The mechanism proposed by Reason and Brand for adaptation to a provocative stimulus (sensory conflict) was detailed in their neural mismatch model (143; 142) using motor control modeling concepts from Von Holst (185). A “comparator” assesses whether there is a satisfactory match between sensory inputs (“re-afference” from vestibular, visual, proprioceptive signals) and a stored pattern of information in a “neural store” (memory). If not, a “mismatch signal” is generated and fed back to the neural store so the store can be updated using the new information (ie, adaptation, a form of learning). In addition, the mismatch signal can produce illusory and reflex phenomena, as well as motion sickness if the mismatch is greater than some threshold. The neural store and comparator were presumed to be located in the cerebellum.

In this model, the neural store receives information about active movements (via a copy of the command signal called an “efference copy”) and then retrieves and reactivates the patterns of reafferent information that had previously been most closely associated with this specific active movement. The comparator then matches the current sensory information with the reactivated reafferent trace combinations and chooses the optimal trace. When there is a mismatch, the error signal is fed back to the neural store to update the trace, a process of feedback presumed to underlie the process of adaptation.

There has been widespread, though not universal, acceptance of this sensory conflict theory, and available experimental data support the general framework and the specific proposition that sensory conflict causes motion sickness, although symptoms are not necessarily proportional to the magnitude of the conflict or mismatch (188; 128).

Other possible mechanisms. Some have proposed a “leaky integrator” to account for the relatively slow development of motion sickness and its persistence for a period after removal of the provocative stimulus (14) whereas others have suggested that some as-yet-unidentified humoral substance is released and is responsible for the persistence of symptoms.

Just as one must adapt to a novel motion environment, one may also have to readapt to the original terrestrial environment on discontinuation of provocative motion. So, for example, not uncommonly with a cruise aboard ship a sensory mismatch occurs on embarkation, followed by a period of adaptation, and then another sensory mismatch occurs again on disembarkation (from the state adapted to being at sea to being back on land), followed by another period of adaptation. The constellation of symptoms and signs associated with embarkation is appropriately termed motion sickness whereas the syndrome on disembarkation is not (because it is not a provocative motion stimulus, but rather the withdrawal of a provocative motion stimulus) and is more appropriately termed mal de debarquement (ie, sickness of disembarkation). Those who experience mal de debarquement are more likely to have experienced motion sickness (178). Generally, readaptation to the original terrestrial environment proceeds more quickly than adaptation to the novel provocative motion environment.

Deficient postural control or abnormal perceptual-motor responses to disorienting conditions may contribute to motion sickness susceptibility (135; 148; 172). Greater postural instability is positively correlated with motion sickness susceptibility (135), and exposure to provocative moving visual stimuli produces increases in postural sway before onset of motion sickness (172).

Vestibular “overstimulation” as a basis for motion sickness was suggested by studies demonstrating that bilateral vestibular hypofunction prevented development of motion sickness (87). If less vestibular activity (from bilateral vestibular dysfunction) prevented development of motion sickness, it seemed reasonable that motion-induced overstimulation of the vestibular system was responsible for development of motion sickness. However, intriguing this idea may seem, it was overly simplistic and wrong. It was unable to explain why relatively weak vestibular stimulation (eg, cross-coupled stimulation, camel riding) is strongly provocative for development of motion sickness compared to much stronger vestibular stimulation (eg, repeated rapid linear acceleration/deceleration, horseback riding) (126; 14).

Regardless of the mechanism involved, motion sick individuals have genuine deficits in selecting and reweighting multimodal sensory information (48). People have idiosyncratic ways of accomplishing sensory reweighting for postural control, and these various processes are linked to motion sickness susceptibility (48). In addition, vestibular morphological asymmetry can be a source of sensory conflicts in individuals with dysfunctional reciprocal visuovestibular interactions (70).

Migraine-associated vertigo and motion sickness may involve distinct susceptibility genes (138).

Neural structures involved in the production of motion sickness. Neural structures involved in the production of motion sickness include afferent vestibular inputs through the semicircular canals and the otolith organs, and the velocity storage integrator in the vestibular nuclei (43). Separate groups of nodular neurons sense orientation to gravity, roll/tilt, and translation and provide strong inhibitory control of the “vestibular-only” neurons (ie, neurons sensitive only to head movement) of the vestibular complex (43). Velocity storage is produced through the activity of “vestibular-only” neurons under control of neural structures in the nodulus of the vestibulo-cerebellum (43). In addition, the left parietal cortex is involved in motion sickness susceptibility as revealed by multimodal magnetic resonance imaging, which was based on (1) greater network centrality of the left intraparietal sulcus in high, rather than in low, susceptible individuals and (2) linkage of motion sickness susceptibility to white matter integrity in the left inferior fronto-occipital fasciculus (153).

Several kinds of neurotransmitters (eg, acetylcholine, histamine, noradrenaline, GABA) are apparently involved in the processes of motion sickness, based on the pharmacological properties of medications found to be helpful in prevention and controlling motion sickness (Wood and 61; 71; 175; 43). Anticholinergic drugs that don’t cross the blood-brain barrier are ineffective in preventing or treating motion sickness; nevertheless, some authors continue to suggest that anticholinergic drugs may alleviate gastrointestinal symptoms of motion sickness by inhibiting peripheral autonomic nervous system and central vestibulo-autonomic pathways (140). Central cholinergic pathways mediate vection-induced tachygastria with additional modulation by alpha-adrenergic pathways (71). Compounds that selectively antagonize muscarinic M3 receptors, M5 receptors, or both, possess activity against motion sickness (58). Cholinergic and histaminergic pathways are presumably involved in the neural pathways involving the vomiting center (161); scopolamine, the most effective anti-motion sickness medication currently available, is thought to act nonspecifically on all subtypes of muscarinic receptors, and specifically on muscarinic receptors in the vomiting center (161). In addition, acetylcholinergic projections from the nodulus to the stomach, along with other serotonergic inputs from the vestibular nuclei, may induce nausea and vomiting (43). GABA_B receptors modulate and suppress activity in the velocity storage integrator; consequently, baclofen, a GABA_B agonist, causes suppression of motion sickness (43).

Based on studies in rats and dogs, activation of the inner ear arginine vasopressin-vasopressin receptor 2-aquaporin 2 signaling pathway may be involved in the development of motion sickness (197). Furthermore, blocking vasopressin receptor 2 (V2R) with mozavaptan, a V2R antagonist, was effective in reducing motion sickness in both animal species (197).

Many of the physiologic changes in subjects with motion sickness result from altered activity of the autonomic nervous system, and increased secretion of pituitary and adrenal hormones (99; 14).

Gastric and colonic motility decrease, with a concomitant decrease in bowel sounds. Myoelectrical activity of the stomach recorded using surface electrodes affixed to the abdomen (ie, an “electrogastrogram”) shows a reduction in amplitude and an increase in frequency of the background rhythm from three cycles per minute to a faster dysrhythmic four to nine cycles per minute, a phenomenon termed “tachygastria” or “gastric tachyarrhythmia” (170; 71; 129; 130; 99; 88; 14). Tachygastria indicates an increase in frequency of gastric pacemaker potentials and not gastric contraction per se, as tachygastria is associated with decreased gastric motility. Experimental animal data suggest that acute hyperglycemia is related to gastrointestinal symptoms in motion sickness, whereas stable glucose levels can help to prevent or relieve gastrointestinal symptoms in motion sickness (125).

Changes in vascular tone accompanying motion sickness depend on the vascular bed: facial pallor is caused by cutaneous vasoconstriction, but other vessels vasodilate, so for example muscle blood flow increases. The pituitary secretes increased amounts of various hormones, but particularly antidiuretic hormone (vasopressin), which contributes to oliguria (in conjunction with dehydration from decreased intake and vomiting) (99; 14). Levels of the adrenal hormones epinephrine and norepinephrine are elevated as a nonspecific stress response.

Space sickness (space adaptation syndrome)

Space adaptation syndrome or "space sickness" is a kind of motion sickness that occurs during space travel when changes in g-forces compromise one's spatial orientation. For affected individuals, their surroundings visually appear to be in motion but without a corresponding sense of bodily motion. This discrepancy, or visual-vestibular mismatch, leads to motion sickness, which can be severe and disabling.

Gallaudet Eleven. In the late 1950s, NASA and the U.S. Naval School of Aviation Medicine established a joint research program to study the effects of altered gravity on the human body before sending humans into space. The joint program recruited 11 deaf men from Gallaudet College (now Gallaudet University in Washington, DC): the “Gallaudet Eleven." All but one had become deaf in childhood due to spinal meningitis, which damaged their eighth cranial nerves, affecting both hearing and peripheral vestibular function. Their bilateral vestibulopathy left them "immune" to motion sickness (just as William James had recognized in the late 19th century). The men participated in a decade of experiments that assessed their resistance to motion sickness from physiological and psychological perspectives. In one experiment, four subjects spent 12 days inside a 20-foot slow rotation room, rotating at 10 revolutions per minute. In another experiment, subjects participated in a series of zero-g flights in the “Vomit Comet” aircraft to assess body orientation and gravitational cues. A third experiment, in a ferry off the coast of Nova Scotia, was meant to test their reactions to the choppy seas. However, although the test subjects were unbothered by the irregular motion, the researchers were so overcome with sea sickness that the experiment had to be canceled.

John Zakutney being lowered into a centrifuge pool

John Zakutney, one of the “Gallaudet Eleven" research subjects in the 1950s, being lowered into a centrifuge pool. (Credits: NASA/U.S. Navy/Personal collection of David Myers. Source: Hotovy/NASA 2017.)
Harry Larson inside a 20-foot slow rotation room

Harry Larson, one of the “Gallaudet Eleven" research subjects in the 1950s, inside a 20-foot slow rotation room, rotating at 10 revolutions per minute. (Credits: Gallaudet University Archives/Harry Larson Collection and NASA. S...

Zero-g and the “Vomit Comet.” The NASA Reduced Gravity Program operated by NASA Lyndon B Johnson Space Center (JSC) in Houston, Texas, provided the "weightless" or zero-g environment of space flight for test and training purposes. This was accomplished using specially equipped jets with parabolic flight trajectories. The maneuver could be modified to provide any level of g-force less than 1 g. Some typical g-levels used on different tests and the approximate corresponding time for each maneuver are as follows: (1) negative-g (-0.1 g), 15 seconds; zero-g, 25 seconds; lunar-g (1/6 g), 40 seconds; Martian-g (1/3 g), 30 seconds. The series of parabolas flown by the KC-135 on a given day represents the only accurate Earth-bound means of fabricating the microgravity environment of space travel.

NASA parabolic maneuvers: C-9B Flight Trajectory for zero-g training

NASA's Reduced Gravity Research Program made it possible for scientists to study human responses to simulated weightlessness. The reduced-gravity aircraft flies an up-and-down parabolic pattern. This provides about 30 seconds o...

Early flights using this approach were used with the Mercury astronauts and German-American aerospace engineer Wernher von Braun (1912-1977), who had been appointed technical director of the American lunar program in 1961. Weightless flights were a new form of training for the Mercury astronauts. These flights were nicknamed the "vomit comet" because of the nausea that is often induced (though this term doesn't appear often in official NASA documents, and a search for the term on the NASA website brought no returns).

Mercury astronauts in simulated weightless flight in C-131 aircraft flying zero-g trajectory

Mercury astronauts in simulated weightless flight in C-131 aircraft flying zero-g trajectory (the "vomit comet") at Wright Air Development Center, 1959. Weightless flights were a new form of training for the Mercury astronauts....
Dr. Wernher von Braun inside the KC-135 in flight during a period of simulated weightlessness

The KC-135 provided NASA's Reduced Gravity Program with a zero-g environment for testing and training of human reactions (1968). (Source: NASA [NAS-9-9-59279-163125]. Public domain.)

Later, the KC-135A was used for NASA's microgravity parabolic flights. The primary mission of the KC-135 is the refueling of American strategic long-range bombers. NASA's version, KC-135A, was a specially modified turbojet transport with a cargo bay test area approximately 60 feet long, 10 feet wide, and 7 feet high. Painted on the aircraft nose was a somewhat modified flight trajectory from that used earlier. Although many of the NASA public relations photographs show astronauts and astronaut candidates enjoying the experience, this was not the case for many.

NASA/U.S. Air Force KC-135 aircrew below the aircraft nose, 1995: "Weightless Wonder IV"

NASA/U.S. Air Force KC-135 aircrew below the aircraft nose, 1995: "Weightless Wonder IV," Johnson Space Center. Note the parabolic flight trajectory painted on the aircraft's nose. (Source: NASA/Glenn Research Center [C-1995-71...
Parabolic flight trajectory of the NASA KC-135A 9 from the aircraft nose of "Weightless Wonder IV"

Parabolic flight trajectory of the NASA KC-135A 9 from the aircraft nose of "Weightless Wonder IV," Johnson Space Center. (Source: NASA/Glenn Research Center. The present image was created from a photograph of the aircraft nose...
KC-135 aircraft ascent phase of parabolic flight trajectory

Note the approximate 45-degree angle of ascent. (Source: NASA Image and Video Library [GRC-2001-C-00614]. Public domain.)
Astronauts experience weightlessness in the KC-135, 1978

In this photo from 1978, six astronauts who had been in training at the Johnson Space Center for almost a year are experiencing weightlessness. They are onboard the NASA KC-135, which uses a special parabolic pattern to create ...
Astronaut candidates experience weightlessness in the KC-135

This August 1995 photo aboard a KC-135 zero-g aircraft carrying that year's class of NASA astronaut candidates depicts the kind of training required to prepare astronauts for flights on assigned missions in space. Those picture...
Space shuttle astronauts training on the KC-135 zero-g aircraft

Space shuttle “Teacher in Space” astronaut Christa McAuliffe (at top), her backup crew member, Barbara Morgan (bottom), and Payload Specialist Greg Jarvis (top right) training on the KC-135 zero-g aircraft. STS-51-L was the 25t...

Soviet cosmonaut Gherman Stepanovich Titov and the first experience of space sickness. In August 1961, Soviet cosmonaut Gherman Stepanovich Titov (Russian: Герман Степанович Титов, 1935-2000) became the first human to experience space sickness on Vostok 2 and, consequently, was the first person to vomit in space—a rather dubious honor that was recognized in the Guinness World Records. Titov was recognized on a Russian stamp in 2010 and a Moldovan stamp in 2011, but, oddly, only the Moldovan stamp lists his occupation or provides some context by the image presented.

Gherman Titov, Nikita Khrushchev, and Yuri Gagarin on the Red Square in Moscow

From left to right: Soviet cosmonaut Gherman Stepanovich Titov (1935-2000); Nikita Sergeyevich Khrushchev (1894-1971), First Secretary of the Communist Party of the Soviet Union; and Soviet cosmonaut Yuri Alekseyevich Gagarin (...
Cosmonaut German Titov, NASA astronaut John Glenn, and President John Kennedy

Cosmonaut German Titov (right) appears with NASA astronaut John Glenn (left) and President John Kennedy (center) at the White House on May 3, 1962. Titov was in Washington to give his account of the Vostok 2 spaceflight to the ...
Moldovan stamp commemorating cosmonaut German Titov's orbit of the Earth on August 6, 1961

(Source: Post of Moldova. Not subject to copyright.)

The Garn scale. Beginning in 1981, U.S. Senator Edwin Jacob "Jake" Garn (b 1932) of Utah pressured NASA to let him fly on a Space Shuttle mission, and in 1985 he was included on the STS-51-D mission of the Space Shuttle Discovery. As a Payload Specialist, Garn's role was as a congressional observer and as a subject for medical experiments on space motion sickness. He did acceptably well in training, including his stint on the KC-135 “Vomit Comet.” Having been a Navy combat pilot, Garn boasted before he boarded the shuttle, “I logged more flying hours than most of the astronauts” (117).

Jake Garn, U.S. politician and astronaut, c 1985

Beginning in 1981, United States Senator Edwin Jacob "Jake" Garn (b 1932), from Utah, pressured NASA to let him fly on a Space Shuttle mission, and in 1985 he was included on the STS-51-D mission of Space Shuttle Discovery. Gar...
STS-51E Crewman Senator Jake Garn during zero-g parabolas on the KC-135 "Vomit Comet"

Garn did acceptably well in training, including his stint on the KC-135 "Vomit Comet." However, while one of the crew (in green flight suit) is moving about in the zero-g environment and clearly enjoying himself, Garn (at left ...

After the launch of STS-51-D from Kennedy Space Center, Florida, on April 12, 1985, Garn spent 6 days, 23 hours, and 55 minutes in space. At the conclusion of the mission, Garn had traveled over 2.5 million miles (4.0 million kilometers) in 108 Earth orbits, logging over 167 hours in space—all that time completely miserable with space sickness! Despite having flown more than 10,000 hours as a Navy combat pilot, the space sickness Garn experienced was so severe that a scale for space sickness was jokingly based on him, where "1 Garn" is the highest possible level of sickness (for a human). Garn suffered from space sickness almost from the very start of the mission and needed help walking after the shuttle landed. Because his only substantive role was to participate as a subject for medical experiments on space motion sickness, the Los Angeles Times mockingly concluded after the mission that Garn had done exactly what was expected of him: "[He] got sick" (50).

The "Garn scale" very quickly came into use by NASA scientists and astronauts. Indeed, it was already in place by the time of the next shuttle mission 2.5 weeks later (Mission STS-51-B of Space Shuttle Challender with launch date April 29, 1985). When Dr. Paul Callahan (1933-2005), the biochemist in charge of the animal experiments for the mission, was asked how sick one of the squirrel monkeys on board was, he replied ''2 Garns" (117). ''I knew exactly how the crew felt,'' the Senator said on Monday after the Challenger blasted off and the first reports came in about the monkey's ‘2-Garn’ sickness." (117).

As the New York Times noted in 1985, "officials [at NASA] do not smile when they hear the term [ie, Garn scale], and some even cringe. For them, space sickness is one of the unresolved problems of space flight. ... More than half of all astronauts have suffered, and no pill, no nostrum and no piece of equipment has been able to reduce their discomfort significantly" (117).

Space adaptation syndrome acclimation

Astronauts and Canadian space medicine researcher and physiologist Douglas Watt (top left) acclimating themselves to space adaptation syndrome in a KC-135 airplane that flies parabolic arcs to create short periods of weightless...

In an oral history interview on May 13, 1999, Dr. Robert E Stevenson (1921-2001), the "Father of Space Oceanography, " recalled Garn's experience with space sickness: “Jake Garn was ... pretty sick. ... Jake Garn, he has made a mark in the Astronaut Corps because he represents the maximum level of space sickness that anyone can ever attain, and so the mark of being totally sick and totally incompetent is one Garn. Most guys will get maybe to a tenth Garn, if that high. And within the Astronaut Corps, he forever will be remembered by that” (Stevenson 1999).

Garn's experience even made it to Time magazine's recounting of the highs and lows of space exploration, before and after Soviet cosmonaut Yuri Gagarin was the first to circle the globe from space (101).

If you had the opportunity to go into orbit, chances are you'd want to spend it doing something other than throwing up. That's probably what former Utah Senator Jake Garn wanted too — but that's not what he got. As one of the purse-string-controlling members of the Appropriations Committee, a particularly good friend for NASA to have, Garn w[r]angled himself a seat on a mission but learned firsthand that space travel is not for junketeers. So notorious were his bouts with space sickness that the comic strip Doonesbury nicknamed him "Barfin' Jake" Garn.

The Gary Trudeau Doonesbury cartoon was published on February 13, 1985, with the final panel showing toilet paper floating in weightlessness: "'Barfin' Jake" Garn. A man and his mission."

Curiously, even though it was expected that animals would have even more difficulty with space adaptation than humans, this was not correct as was evident even from the Shuttle Challenger flight at the end of May 1985: "Dr. William E. Thornton, one of two physician-astronauts serving on the Spacelab where the animals are caged, said the Boston monkey was ill briefly after liftoff, but that he himself would have liked to have adapted to the rigors of space as quickly as the monkeys had" (116).

Sensory conflict between semicircular duct and utricular signals. The utricle senses the sum of inertial force due to head translation and head tilt relative to gravitational vertical. Changing from 1-g (Earth) to 0-g (space) environments, an astronaut experiences difficulties in orientation and instability, resembling those of a patient with an acute vestibulopathy (54; 25). Adaptation to the weightless state and readaptation after space flight to the 1-g environment on the ground are both accompanied by various transitory symptoms of vestibular instability, motion sickness (kinetosis), and illusory sensations (184). Utricular adaptive responses to changes in gravity are needed to resolve the underlying conflict, allowing the disorientation to subside. It often takes days for astronauts to recover to tolerable conditions in weightlessness. Similarly, following even relatively short exposures to weightlessness, the astronaut must readapt to the “new” gravity on Earth.

In microgravity, the absence of gravitational stimulation of the otolith organs and the occasional stimulation of the semicircular canals by head and body movements is a form of sensory mismatch, or sensory conflict, between the canal and otolith signals that can elicit motion sickness (54; 44). Experiments in parabolic flights and in spacecraft showed that the otolith organs do respond to changes of acceleration in zero-g environments (54). During the transition from 1-g to zero-g, the frequency of nerve impulses from the otolith organs is initially transiently increased but then becomes drastically decreased before finally dropping to a steady discharge rate that is somewhat lower than normal level (54).

Oculogravic, audiogravic, and somatogravic illusions. Graybiel and colleagues noted in the early 1950s that human subjects experience visual illusions during centrifugation; in particular, a real target and a visual afterimage seemed to rise in the visual field when the subjects were looking toward the axis of rotation ("oculogravic illusion") (60; 60). This and related phenomena have been investigated in a series of experiments spanning more than 60 years (60; 60; 27; 36; 37; 38; 65; 63; 44). The oculogravic illusion is caused by linear acceleration or deceleration, which gives a feeling of a false climb or descent, respectively. Individuals exposed to both a change in magnitude and a rotation of the gravitoinertial acceleration vector experience changes in visual and auditory localization and apparent body orientation—the oculogravic, audiogravic, and somatogravic illusions, respectively (103). The occurrence of these multimodal effects, acting in parallel, suggests that the internal spatial reference system is shifted or remapped in response to the changes in gravitoinertial acceleration ("gravitoinertial acceleration-induced remapping of a peripersonal spatial referent") (103). Part of this illusion is caused by eye movements that are triggered by the changing input from the otolith system, and another part is based on a change of the subjective horizontal (184).

Caloric reactions in weightlessness. The standard thermal convection mechanism of the caloric nystagmus is from Robert Bárány’s publications from 1906 and 1907, work for which he was awarded the Nobel Prize in Medicine or Physiology in 1914 (although there were subsequent allegations that he usurped the work of others) (10; 09; 07). With the patient supine with head up 30 degrees, so that the lateral (horizontal) semicircular canal is oriented vertically, instillation of cold or hot water or air will induce a thermal change in the density of the endolymph of the nearby horizontal canal (which is the semicircular canal located closest to the tympanic membrane) and a resulting thermal convection in the endolymph. This convection current then causes cupular deflection (ampullopetal with cold stimuli, and ampullofugal with warm stimuli).

Stahle summarized it as follows:

Four arguments against Bárány's theory have been put forward: that (1) a caloric response can be elicited from "dead" ears [or ears with canal plugging], (2) the two points of reversal of the caloric response from right- to left-beating do not lie 180 degrees apart, (3) the duration of the caloric response, to both cold and warm stimuli, is greater in the face-up than in the face-down position, and (4) caloric nystagmus can also be evoked in a weightless environment (167).

Bárány's thermoconvective theory would predict that the intensity of the caloric nystagmus would be equal in intensity in the supine and prone positions (though oppositely directed) and that the head positions in which the nystagmus reverses direction should be 180 degrees apart in the pitch plane. However, it has been known since the 1940s that caloric responses are stronger in a supine than a prone position and that the reversal points are not 180 degrees apart (12; 13; 122; 41; 107).

Coats and Smith studied the relationship between the caloric response and body position through 360 degrees in the pitch plane (41). The maximum response was in the supine position with the head elevated 30 degrees; a rotation of 180 degrees in the pitch plane reversed the direction of nystagmus, but the nystagmus was then of lesser intensity. The supine-prone asymmetry and the other findings suggested that the caloric response was comprised of two components: (1) the standard gravity-dependent convective mechanism and (2) a nonconvective component that does not vary with gravity or, hence, head position and that results in excitation with warm stimuli and inhibition with cool stimuli. With the head 30 degrees up from supine, these different mechanisms are additive, whereas in the prone position with the head down 30 degrees, the two mechanisms operate against each other, with the typical thermoconvective component still dominating (but in any case, with less intense caloric nystagmus in this position because of the oppositely directed effects). Coats and Smith suggested a direct thermal effect on the hair cells or vestibular nerve.

Several human and animal experiments have also been done in subjects with plugging of the horizontal canal (duct). For example, Young and Lowry studied a patient with a unilateral plug of granulation tissue in the horizontal duct (200). Caloric stimuli on the nonplugged side produced nystagmus that reversed directions in the supine and prone positions, whereas caloric stimuli on the plugged side did not vary in the supine and prone positions (slow-phase deviations were ipsilateral with cold stimuli). As the authors concluded, “The findings imply that a caloric mechanism exists which is independent of the conventionally accepted one involving convection currents within the canal.”

During the European Spacelab mission (SL1) in 1983, caloric testing in long-term weightlessness demonstrated that unequivocal caloric nystagmus as present after 2 days of orbital flight (157; 159). When I was a resident in Neurology at University Hospitals in Cleveland, the Spacelab experiments were actively discussed, as were issues of space motion sickness and caloric reactions in microgravity, primarily by Robert Daroff and R John Leigh (109). I was fortunate to have been included in one of their discussions concerning the effect of testing caloric reactions prone versus supine and the implications of the Spacelab experiments. In 2014, after an Oral History Interview of Robert Daroff for the American Academy of Neurology (104), I asked John Leigh to elaborate on his recollections of that time (Leigh RJ 2014, personal communication).

Spacelab 2 showed that it was possible to elicit nystagmus in microgravity by blowing cold (very cold) air into astronauts' ears. Barany had postulated that nystagmus induced by hot and cold irrigation of the external auditory canal was due to a convection current being induced in the endolymph of the labyrinth. Such a convection current should not occur in microgravity. However, as Gary Page [sic Paige MD PhD] nicely showed, there are two mechanisms when in earth gravity -- the most important is the convection current, but cooling the ear also decreases the spontaneous firing rate of vestibular afferents, thereby inducing an imbalance and nystagmus. That was the report. [See (136).]

The anecdote is that Bob [Daroff] was unconvinced about Gary's result and so I bet him a six-pack of Bass Ale that if he induced (cold) caloric nystagmus in me supine, and then I turned prone, the direction of my nystagmus would reverse [because the direction of the convection current depends on gravity]. We did this experiment, with me lying on the table in our conference area and, as I turned from supine to prone, I nearly vomited, but I proved my case and won the six-pack.

A modern comment is that the stronger MRI fields commonly cause vertigo and induce nystagmus by causing endolymph motion (since endolymph carries a weak charge due to the electrolytes). David Zee has written some nice papers [sic, a nice paper] about this. [See (149).]

The current understanding of the caloric reaction is that both a gravity-dependent, thermal-convective mechanism and a simultaneous gravity-independent, non-convective thermal mechanism act together in the caloric response (155; 156; 158; 66). In regular clinical testing, the thermal convective mechanism is dominant. However, the other mechanism explains the problems leveled against Bárány's theory as the sole explanation of the caloric reaction. Various explanations of the gravity-independent mechanism have been suggested, including changes in endolymphatic pressure within the semicircular duct, a direct thermal effect on vestibular hair cells, etc. Animal experiments suggest that a direct thermal effect on hair cells is the most likely explanation (201; 174), but it is possible that multiple contributing mechanisms are involved in the generation of the caloric reaction in weightlessness.

There are additional issues that complicate interpretation of the available studies, including the discrepant findings of a disappearance of caloric nystagmus during short episodes of weightlessness and the presence of caloric nystagmus during periods of extended weightlessness (39; 40). Even the issue of convection is now controversial based on experiments in animals (181).

The history of vestibular experiments in space. Vestibular experiments have been one of the top priorities of Skylab, Spacelab, and the International Space Station (146).

Skylab vestibular experiments. Skylab was the first United States space station, which was occupied for about 24 weeks between May 1973 and February 1974. It was operated by three separate 3-astronaut crews: Skylab 2, Skylab 3, and Skylab 4. Skylab's orbit eventually decayed, and it disintegrated in the atmosphere on July 11, 1979, scattering debris across the Indian Ocean and Western Australia.

The Skylab program studied the human body's reaction to long-duration flight in a microgravity (weightless) environment. Skylab astronauts used a rotating "litter chair" to test their balance, coordination, and susceptibility to motion sickness in space. Data were collected about changes in human gravity receptors and about the sensitivity of the semicircular canals of the inner ear where motion is perceived. The motion tests were conducted on each of the long-duration flights of 28, 59, and 84 days in 1973 and 1974.

The Rotating "Litter Chair," a major component of Skylab's Human Vestibular Function experiment

(January 1, 1970) The Rotating "Litter Chair" was a major component of Skylab's Human Vestibular Function experiment (M131). The experiment was a set of medical studies designed to determine the effect of long-duration space mi...
Skylab vestibular experiments of the oculogyric illusion

(January 1, 1972) Skylab's Human Vestibular Function experiment (M131) was a set of medical studies designed to determine the effect of long-duration space missions on astronauts' coordination abilities. This experiment tested ...
Skylab vestibular experiments: spatial localization test

(January 1, 1972) The control panel is at the upper left. The base houses the motor for the rotary chair. Skylab's Human Vestibular Function experiment (M131) was a set of medical studies designed to determine the effect of lon...
Skylab vestibular experiments: motion sensitivity test in a rotary chair

(January 1,1972) The base houses the motor for the rotary chair. Skylab's Human Vestibular Function experiment (M131) was a set of medical studies designed to determine the effect of long-duration space missions on astronauts' ...
Astronauts Conrad and Kerwin conduct a human vestibular function experiment

(March 1, 1973) Astronaut Charles Conrad Jr (1930-1999), commander of the first manned Skylab mission, serves as a subject in Human Vestibular Function Experiment M131 during Skylab training at Johnson Space Center. Scientist-a...
Astronaut Conrad conducts a human vestibular function experiment

(March 1,1973) Astronaut Charles Conrad Jr (1930-1999), commander of the first manned Skylab mission, serves as a subject in Human Vestibular Function Experiment M131 during Skylab training at Johnson Space Center. Conrad is in...
Rotary chair vestibular experiment in Skylab

(August 9, 1973) Scientist-astronaut and electrical engineer Owen K Garriott (1930-2019), Skylab 3 science pilot, serves as a test subject for the Skylab Human Vestibular Function M131 experiment in this image from a television...
Rotary chair vestibular experiment in Skylab

(August 9, 1973) Scientist-astronaut and electrical engineer Owen K Garriott (1930-2019), Skylab 3 science pilot, serves as a test subject for the Skylab Human Vestibular Function M131 experiment, as seen in this image from a t...

Spacelab vestibular experiments. Spacelab was a reusable laboratory developed by the European Space Agency (ESA) and was used on spaceflights flown by the U.S. Space Shuttle. Spacelab allowed scientists to perform experiments in microgravity in geocentric orbit. There were at least 22 major Spacelab missions between 1983 and 1998.

Vestibular experiments performed during the flight of Spacelab-1 included caloric stimulation with and without linear accelerations, threshold measurements of response to linear acceleration, assessment of response to motion sickness provocative stimuli, optokinetic stimulation, tests of vestibulo-ocular reflexes during linear and angular stimulation, estimation of the subjective vertical, and assessment of static ocular counterrotation at various tilt angles, using a tilt table (93; 94; 183; 15; 16; 17; 157; 182). The caloric experiment proved that caloric nystagmus may occur in space by a mechanism other than thermoconvection (93; 157; 183). Other tests indicated a greater dependence on visual and somatosensory cues, rather than otolith cues, in the microgravity environment. The raised threshold to perception of linear acceleration in flight and the temporary reduction of ocular counterrotation at lateral tilts postflight suggest a decreased gain of the otolith system as a possible effect of space vestibular adaptation.

Vestibular experiment on Earth-orbiting space shuttle Columbia

(November 16, 1982) Astronaut Joseph P Allen IV (b 1937), one of two mission specialist astronauts for STS-5, participates in a biomedical test in the middeck area of the Earth-orbiting space shuttle Columbia. A series...
Vestibular experiment in Spacelab (1)

(November 1, 1983) In this photograph, scientist-astronaut and electrical engineer Owen K Garriott (1930-2019) on the body restraint system and astronaut, fighter pilot, and engineer Byron Lichtenberg (b 1948) prepare for a ves...
Vestibular experiment in Spacelab (2)

(November 1, 1983) In this Spacelab-1 mission onboard photograph, astronaut, fighter pilot, and engineer Byron Lichtenberg (b 1948) performs a drop experiment, one of the Vestibular Experiments in Space investigations. The expe...
French Postural Experiment on the Earth-orbiting Space Shuttle Discovery

(June 17, 1985) The two Payload Specialists for the week-long flight share a mid-deck scene on the Earth-orbiting Space Shuttle Discovery. On the left, Saudi astronaut Sultan Salman Abdelazize Al-Saud (b 1956) is eatin...
Payload Specialist Sultan Abdelazize Al-Saud conducts a postural experiment

(June 17, 1985) Saudi astronaut and Payload Specialist Sultan Salman Abdelazize Al-Saud (b 1956) participates in the French Postural Experiment on the mid-deck of the Earth-orbiting Space Shuttle Discovery. (Source: NA...
Spacelab laboratory module in the cargo bay of the Space Shuttle Orbiter Columbia

(June 5, 1991) The laboratory module in the cargo bay of the Space Shuttle Orbiter Columbia was photographed during the Spacelab Life Science-1 (SLS-1) mission. SLS-1 was the first Spacelab mission dedicated solely to ...
STS-40 crewmembers conduct a vestibular experiment on Space Shuttle Columbia

(June 14, 1991) Vestibular experiment activities were captured onboard Columbia's Spacelab Life Sciences (SLS-1) module in this 35 mm scene. Astronaut and physician-engineer James P Bagian (b 1952), STS-40 mission spec...
Rotary chair experiments in Spacelab (1)

(Jan 30, 1992) Canadian astronaut and neurologist Roberta L Bondar (b 1945), STS-42 Payload Specialist, gets into the Microgravity Vestibular Investigations (MVI) rotator chair to begin an experiment. The chair is mounted in th...
Rotary chair experiments in Spacelab (2)

(Jan 30, 1992) Astronaut and physician David C Hilmers (b 1950), STS-42 mission specialist, wearing a helmet assembly, sits in the Microgravity Vestibular Investigation (MVI) rotating chair. The scene is in the International Mi...
STS-55 Pilot Henricks with baroreflex collar in the Spacelab D2 science module onboard Space Shuttle Columbia

(May 6, 1993) Terence T (Tom) Henricks (b 1952), STS-55 pilot, wears a special collar for a space adaptation experiment in the science module onboard the Earth-orbiting Space Shuttle Columbia
(OV-102). The Baroref...
Spacelab pre-flight data collection concerning neurovestibular function

(September 29, 1993) Astronaut and surgeon Rhea Seddon (b 1947), STS-58 Payload Commander, is in a piloting simulator as part of a preflight data collection project concerning neurovestibular function. The seven Spacelab Life S...
Crewmembers in the Spacelab with the rotating dome vestibular experiment

(November 1, 1993) In the Spacelab onboard the Space Shuttle Columbia, STS-58 Commander John Blaha (b 1942) is positioned at the rotating dome vestibular experiment as Payload Commander, and surgeon Rhea Seddon (b 1947...
Crewmember in Spacelab wearing the acceleration recording unit and collar

(November 1, 1993) Astronaut and surgeon Rhea Seddon (b 1947), STS-58 Payload Commander, spins the Spacelab Life Sciences (SLS-2) rotating chair as Payload Specialist and pathologist Martin J Fettman (b 1956) serves as test sub...

International Space Station (ISS) vestibular experiments. The International Space Station (ISS) is the largest artificial object in space and is regularly visible to the naked eye from Earth's surface. It maintains an orbit with an average altitude of 400 kilometers (250 miles) by means of reboost maneuvers using the engines of the Zvezda Service Module or visiting spacecraft. The ISS circles the Earth in about 93 minutes, completing 15.5 orbits per day.

The ISS is a multinational collaborative project involving five participating space agencies: NASA, the Russian State Space Corporation "Roscosmos," the Japan Aerospace Exploration Agency (JAXA), the European Space Agency (ESA), and the Canadian Space Agency (CSA). Construction effectively began with the launch of the first component in 1998, although the first long-term residents did not arrive until November 2, 2000. The station has since been continuously occupied, serving as a microgravity and space environment research laboratory that continues to be used for neurovestibular experiments.

Short-arm centrifuge

(January 12, 2003) The short-arm centrifuge subjects an astronaut to conflicting sensory input and is used to study the astronaut's perception of motion. It was part of the Spatial Reorientation Following Space Flight investiga...
Crewmember at the International Space Station performs the commissioning of the Gravitational References for Sensimotor Performance (GRASP) experiment...

(May 24, 2017) European Space Agency astronaut and French aerospace engineer Thomas Pesquet (b 1978) performs the commissioning of the Gravitational References for Sensorimotor Performance (GRASP) experiment on the Internationa...
Crewmember at the International Space Station performs the commissioning of the Gravitational References for Sensimotor Performance (GRASP) experiment...

(May 24, 2017) European Space Agency astronaut and French aerospace engineer Thomas Pesquet (b 1978) performs the commissioning of the Gravitational References for Sensorimotor Performance (GRASP) experiment. (Source: NASA/John...

After the U.S. Space Shuttle program ended in 2011, NASA relied on Russia to ferry U.S. astronauts to and from the ISS. U.S. astronauts launched on Soyuz rockets from the Baikonur Cosmodrome (a spaceport in an area of southern Kazakhstan leased to Russia) from 2011 to 2020. American and European astronauts participated with Russian cosmonauts in joint preflight training and vestibular experiments and cooperated during missions as well.

American astronaut "testing vestibular skills" at the Cosmonaut Hotel crew quarters in Baikonur, Kazakhstan

(December 11, 2017) At the Cosmonaut Hotel crew quarters in Baikonur, Kazakhstan, Expedition 54-55 prime crewmember Scott Tingle (b 1965) of NASA tests his vestibular skills on a rotating chair as part of his prelaunch training...
German astronaut "takes a spin" in a rotating chair at the Cosmonaut Hotel crew quarters in Baikonur, Kazakhstan

(May 29, 2018) At the Cosmonaut Hotel crew quarters in Baikonur, Kazakhstan, Expedition 56 prime crewmember Alexander Gerst (b 1976), a German astronaut of the European Space Agency, "takes a spin" in a rotating chair to test h...
Tilt table testing at the Cosmonaut Hotel crew quarters in Baikonur, Kazakhstan (1)

(March 15, 2018) At the Cosmonaut Hotel crew quarters in Baikonur, Kazakhstan, Expedition 55 crewmembers Andrew ("Drew") Feustel (b 1965) of NASA (top) and Richard ("Ricky") Arnold (b 1963) of NASA (bottom) conduct tests of the...
Tilt table testing at the Cosmonaut Hotel crew quarters in Baikonur, Kazakhstan (2)

(July 12, 2019) At the Cosmonaut Hotel crew quarters in Baikonur, Kazakhstan, Expedition 60 crewmembers Luca Parmitano (b 1976), an Italian astronaut of the European Space Agency (foreground), and Andrew ("Drew") Morgan (b 1976...

With the launch of Crew Dragon Demo-2 in 2020 (also called Crew Demo-2, SpaceX Demo-2, or Demonstration Mission-2), the U.S. regained the ability to shuttle its own astronauts, the significance of which has gained further salience following the 2022 Russian invasion of Ukraine and subsequent international sanctions on Russia. Russia has reported that it intends to quit the ISS and is working to develop its own orbital station but has presented conflicting information on when the transition will take place.

Diagnostic workup

• History and physical examination are usually sufficient to diagnose motion sickness and no diagnostic tests are generally required.

History and physical examination are usually sufficient to diagnose motion sickness and no diagnostic tests are generally required. However, it should, of course, be remembered that individuals in provocative motion environments may develop other medical illnesses such as gastroenteritis (eg, norovirus exposure on cruise ships) that may present with pallor, nausea, and vomiting.

For research purposes various studies have sought to identify vestibular testing abnormalities in patients with motion sickness susceptibility, with somewhat variable results (59; 141; 119; 131; 75). To date, no clear relationship with predictive power has been established for a measure of vestibular function and motion sickness susceptibility (14). Gordon and colleagues reported that subjects susceptible to motion sickness had significantly higher vestibular-ocular reflex gain, and lower phase lead than nonsusceptible subjects using sinusoidal harmonic acceleration testing with a rotary chair (59). Quarck and colleagues reported no correlation between horizontal canal-ocular reflex gain and motion sickness susceptibility, but a positive correlation with the time constant and a negative correlation with otolith-ocular reflex magnitude (141). Mallinson and Longridge found no relationship between the response to caloric testing and development of motion sickness (119). Hoffer and colleagues reported abnormal vestibulospinal reflex function in 70% of those with motion sickness susceptibility on dynamic platform posturography, and abnormal time constants in 60% on rotary chair step-velocity testing (75).

Management

	• Prevention or reduction in the severity of motion sickness can be achieved by avoiding provocative motion environments, or, when such environments cannot be avoided, by either decreasing the intensity of provocative stimuli or increasing individual tolerance to provocative motion.
	• Several behavioral countermeasures are helpful to decrease provocative stimuli.
	• Eliminating visual input may reduce visual/nonvisual sensory conflict by decreasing the influence of the visual channel.
	• Increasing individual tolerance can be facilitated by gradual exposure to progressively more intense provocative motion.
	• Few medications have been proven in laboratory or field trials to be more effective than placebo and none of the available beneficial medications provide complete protection and none are without side effects.
	• Scopolamine and antihistamines are the most effective drugs to control the vegetative symptoms associated with motion sickness.
	• Transdermal scopolamine (l-hyoscine) is probably the most effective available medication for prevention of motion sickness.

Behavioral and environmental modifications. Prevention or reduction in the severity of motion sickness can be achieved by avoiding provocative motion environments, or, when such environments cannot be avoided, by either decreasing the intensity of provocative stimuli or increasing individual tolerance to provocative motion (ie, avoidance, minimization, and habituation to motion stimuli) (110). When riding in a car, for example, factors that increase risk of developing motion sickness include reading a book, sitting in the rear seat, stress, on-board smells, and higher on-board temperature (139).

Several behavioral countermeasures are helpful to decrease provocative stimuli. To minimize visual-vestibular mismatch, it helps to be able to have correct visual cues for orientation. Active head tilt towards the centripetal direction and keeping the eyes open greatly reduces the severity of motion sickness (186). It also helps to direct attention to a stable orientational reference (eg, looking at the horizon while aboard ship, or looking out through the windshield at a distant point ahead while a passenger in the front seat of a car, as opposed to looking out a side window from the back seat, or worse trying to read), to avoid enclosed cabins, and to avoid focusing on nearby objects (eg, waves, other vehicles) and especially tasks involving visual search of nearby objects (eg, reading or map reading) (179; 180; 161; 128). Sailors long ago recognized the helpfulness of fixating on the horizon to minimize the likelihood of developing sea sickness, as expressed by Hill:

. . . some measure of harmony can be restored to [a sailor’s] discordant perceptions if he can be persuaded to concentrate all his attention on the horizon while walking, keeping a ‘blind spot’ for the intervening waves. . . . If he succeeds in fixing his gaze upon this datum line of stability, he will find that his legs are now guided by his eyes in co-operation, not competition, with his labyrinths (74).

Anticipation of true motion is helpful, which is maximized by controlling the trajectory, acceleration, and deceleration of a vehicle: of those aboard, the driver, skipper, or pilot is the least likely to suffer motion sickness (165; 14; 33; 82). Compared to the driver, passengers experience more conflicts among multimodal sensory systems and a greater demand for neurophysiological regulation (82).

Some even find it helpful to close the eyes to minimize conflicting visual cues, although this is often not feasible, and some find this more anxiety provoking. To minimize the intensity of the provocative motion stimuli, it is helpful for susceptible individuals to position themselves within a vehicle where low frequency heave acceleration (linear vertical motion) is least, so low-down and near the center of a ship, or near the wing roots of a plane (“over the wing” in airline parlance) (53; 14). With simulator motion sickness, optical correction of the mismatch between the actual distance to the screen and the depicted distances in the simulator’s graphics can significantly reduce (but not eliminate) simulator sickness; airflow also helps (28; 47). Other actions that can sometimes help include lying down in a supine (not prone) position (85; 126; 53; 14; 128); taking off outer layers of clothing, maintaining a lower ambient temperature; providing a fresh breeze on the face (eg, by rolling down the window in a car); regular, deep, slow breathing (89; 198; 199; 128); and listening to music (128).

Consistent with the sensory conflict theory of motion sickness, eliminating visual input may reduce visual/nonvisual sensory conflict by decreasing the influence of the visual channel (86). For example, visual occlusion can decrease motion sickness in a simulator by delaying onset and decreasing severity of symptoms (86). Allocating less attention to central vision during vection also correlates with less motion sickness (191).

Motion sickness may not be governed entirely by an inter-sensory conflict per se, but by beliefs concerning the actual self-motion. In an experiment, illusory self-motion and motion sickness were elicited in healthy human subjects who were seated on a stationary rotary chair inside a rotating optokinetic drum; motion sickness was positively correlated with the discrepancy between subjects' perceived self-motion and their beliefs about the actual motion (132).

Controlled diaphragmatic breathing may be helpful for managing motion sickness in a virtual realty environment (151; 173).

The role of diet is less clear, as some have reported that protein-predominant foods are helpful (111), whereas others have reported the opposite (114). Also, fatty meals (51), high-calorie meals (114), high sodium foods (114), and foods high in thiamin (114) have been associated with motion sickness susceptibility, but it is not clear that any of these reported associations reflect a direct causal relationship.

Increasing individual tolerance can be facilitated by gradual exposure to progressively more intense provocative motion (128). Once habituation has been achieved, regular exposure to the provocative motion stimulus is necessary to maintain it. This can work effectively for sailors and aviators but is not feasible for most individuals who are only occasionally exposed to provocative motion stimuli. More formal desensitization therapy approaches, or variants that include other adapting stimuli (eg, vertical linear oscillation or optokinetic stimuli), sometimes combined with biofeedback and “autogenic therapy” (to help develop an individual’s ability to control autonomic responses) have been used with military personnel (eg, pilots and flight personnel) and occasionally with civilians (14). In addition, verbal suggestions combined with a conditioning procedure can be effective in reducing symptoms of motion sickness (76). Sleep deprivation can accentuate motion sickness severity and decrease the rate of adaptation to motion sickness (91).

Even something as simple as chewing gum may be useful as an affordable, acceptable, and easy-to-access way to mitigate motion sickness (95).

Pharmacotherapy. Pharmacotherapy should be considered in the prevention or treatment of severe motion sickness, particularly for patients who do not respond to conservative measures. Unfortunately, few medications have been proven in laboratory or field trials to be more effective than placebo, and none of the available beneficial medications provide complete protection and none is without side effects (see Table 1) (129; 14; 56). Most of the studies have been conducted on young healthy men (128).

Antimuscarinics (especially scopolamine) and antihistamines are the most effective drugs to control the vegetative symptoms associated with motion sickness (160; 56; 110; 92; 98). These anti-motion sickness medications are most effective when combined with behavioral and environmental modifications (110).

Table 1. Anti-Motion Sickness Drugs Available in the United States

Drug	Route	Adult Dose (mg)	Time of Onset (h)	Duration of Action (h)
Scopolamine (Transderm Scop)	transdermal (patch)	1.5*	6 to 8	72
Promethazine	oral	25 to 50	2	15
Dimenhydrinate (Dramamine)	oral	50 to 100	2	8
Meclizine (Antivert)	oral	25 to 50	2	8
* Programmed to deliver approximately 1.0 mg over 3 days.

Transdermal scopolamine (l-hyoscine) is probably the most effective available medication for prevention of motion sickness (14; 166). Scopolamine is a centrally active, muscarinic cholinergic antagonist. Scopolamine is not well tolerated by children or the elderly and can aggravate glaucoma or bladder outlet obstruction as in benign prostatic hypertrophy (113). The transdermal patch provides a loading dose of 200 µg, followed by controlled release of 20 µg/hour for up to 3 days. The patch should be applied to the hairless area behind the ear at least 4 to 6 hours before needed. Common side effects include dry mouth (approximately two thirds of patients), drowsiness (less than one sixth of patients), and impaired accommodation with blurred vision and pupillary dilation. Other reported side effects include precipitation of acute angle-closure glaucoma; dry, flushed skin; difficulty urinating; confusion or delirium; memory disturbances; acute psychosis; and hallucinations. Scopolamine may also delay or dampen habituation (128).

Although scopolamine is an effective prophylactic medication, both oral and transdermal formulations are slowly absorbed. Intranasal scopolamine is a promising and well-tolerated alternative for use in dynamic operational environments without significant cognitive or other side effects (163; 168). Unfortunately, more work is still needed to identify optimal intranasal formulation and dispensing methods (168).

Several medications that were developed primarily for their antihistaminic properties are also effective for motion sickness prophylaxis, including promethazine, dimenhydrinate, and meclizine (14; 190). All of these medications are histamine H1-receptor antagonists, but all have central anticholinergic activity as well (14). All of them can cause drowsiness, particularly promethazine and dimenhydrinate. Other side effects include dry mouth, blurred vision, and dizziness.

According to a Cochrane review, first-generation antihistamines probably reduce the risk of developing motion sickness symptoms under naturally occurring conditions of motion in motion sickness-susceptible adults but, compared to placebo, are more likely to cause sedation (92). No studies have evaluated the treatment of existing motion sickness, and few data concern the effect of antihistamines in children. Existing comparisons with scopolamine, antiemetics, and acupuncture are of low or very low certainty (92).

In migraineurs, prophylactic medication for migraine improves the headaches but also improves associated dizziness and motion sickness (108).

Ginger may also be helpful but randomized, blinded, controlled clinical trials are needed (133). Pretreatment with ginger (1 to 2 gm) reduced nausea, tachygastria, and vasopressin release induced by circular vection (112).

Phenytoin at plasma concentrations of 10 to 20 µg/mL is also effective at increasing tolerance to provocative motion, but its use for motion sickness prophylaxis is not recommended because of its narrow therapeutic index, the nonlinear relationship between dose and plasma concentration, and the potential for significant side effects and drug interactions (14; 02).

Amphetamines combined with scopolamine were used empirically for motion sickness in World War II, and later, in the 1960s amphetamines were demonstrated to increase tolerance to provocative motion and to have an additive preventive effect when combined with scopolamine while minimizing some of the drowsiness often associated with scopolamine (14). Subsequently, this combination was used extensively in the space program to minimize space sickness (“space adaptation syndrome”), and it has been studied more recently in combination with promethazine (190). However, because of its addictive potential, amphetamine has not found general utility among civilians (161; 128). Another central nervous system stimulant, modafinil, has not been found effective, but a combination of modafinil and scopolamine allowed experimental subjects to tolerate significantly more head tilts than placebo (78). The combination of modafinil and scopolamine can counteract some of the side effects experienced from scopolamine, including anxiety (202).

Parenteral or rectal administration of antiemetic medications may be necessary for the treatment of severe vomiting due to motion sickness. Once vomiting is controlled, fluid losses can usually be replaced by mouth, but in severe cases or when vomiting has not been controlled, intravenous replacement of fluids and electrolytes may be necessary.

The serotonin agonist, rizatriptan, can reduce vestibular-induced motion sickness in migraineurs, apparently by influencing serotonergic vestibular-autonomic projections (52).

Deceptive placebos, but not nondeceptive open-label placebos, reduce nausea associated with virtual reality, raising questions regarding the utility of open-label interventions for nausea related to motion sickness (11).

Other treatments. In a prospective randomized crossover study, transcutaneous electrical acustimulation ameliorated motion sickness induced by a rotary chair in healthy subjects (203). Transcutaneous electrical acustimulation involves applying a low-intensity electrical current to acupuncture points without puncturing the skin. Compared with sham transcutaneous electrical acustimulation, transcutaneous electrical acustimulation significantly prolonged the total tolerable rotation time of motion sickness stimuli, lowered motion sickness symptom scores, improved the percentage of normal gastric slow waves, and significantly enhanced vagal activity compared with sham transcutaneous electrical acustimulation. In addition, the increased serum levels of arginine vasopressin and norepinephrine on motion sickness stimulation were markedly suppressed by transcutaneous electrical acustimulation treatment compared with sham transcutaneous electrical acustimulation.

In a preliminary study, transcranial direct current stimulation (ie, unipolar cathodal stimulation) over the left parietal cortex can reportedly suppress the vestibular system, increase the time to develop moderate nausea during off-vertical axis rotation, and facilitate recovery from motion sickness symptoms (05). In contrast, anodal stimulation produced no significant effects, excluding both adaptation and nonspecific effects due to transcranial direct current stimulation.

Noisy vestibular stimulation can reduce simulator sickness, but its utility across a broader range of motion sickness conditions has not yet been evaluated (189).

Media

References

01: Akdal G, Özçelik P, Balcı B, Halmágyi GM, Ünal B. One simple question detects motion sickness susceptibility in migraine patients. Braz J Otorhinolaryngol 2024;90(2):101382. PMID 38219449
02: Albert EG. Phenytoin for the prevention of motion sickness. Med J Aust 2003;178:575-6. PMID 12765507
03: Anonymous. Irwin, John Arthur. In: The national cyclopaedia of American biography: being the history of the United States as illustrated in the lives of the founders, builders, and defenders of the Republic, and of the men and women who are doing the work and moulding the thought of the present time. Volume II. New York: James T White & Co., 1892:151.
04: Anonymous. Cures for seasickness. Pacific Med Surg J 1881;24:143.
05: Arshad Q, Cerchiai N, Goga U, et al. Electrocortical therapy for motion sickness. Neurology 2015;85(14):1257-9. PMID 26341870
06: Baloh RW. Neurotology of migraine. Headache 1997;37:615-21. PMID 9439080
07: Baloh RW. Robert Bárány and the controversy surrounding his discovery of the caloric reaction. Neurology 2002;58(7):1094-9. PMID 11940699
08: Barabas G, Matthews WS, Ferrari M. Childhood migraine and motion sickness. Pediatrics 1983;72:188-90. PMID 6866603
09: Barany R. Physiologie und Pathologie des Bogengangapparates beim Menschen. Vienna: Deuticke, 1907.
10: Barany R. Untersuchungen ueber den vom Vestibularapparat des Ohres reflektorisch ausgelösten rhythmischen Nystagmus und seine Begleiterscheinungen. Monatschr Ohrenheilk 1906;40:193-297.
11: Barnes K, Yu A, Josupeit J, Colagiuri B. Deceptive but not open label placebos attenuate motion-induced nausea. J Psychosom Res 2019;125:109808. PMID 31426018
12: Behrman W. Über Indifferenzlagen und Nystagmusgebiete. Acta Otolaryngol (Stockh) 1940;Suppl 40:1-61.
13: Behrman W. Über Indifferenzlagen und Nystagmusgebiete Versuche mit horizontal liegenden, nach einseitiger kalorischer Reizung um ihre Längsachse rotierten Personen. Acta Otolaryngol (Stockh) 1942;30:298-310.
14: Benson AJ. Motion sickness. In: Pandolf KB, Burr RE III, editors. Medical aspects of harsh environments, Vol. 2 (Textbooks of Military Medicine). Washington, D.C.: Office of the Surgeon General, 2002:1048-83.
15: Benson AJ, Kass JR, Vogel H. European vestibular experiments on the Spacelab-1 mission: 4. Thresholds of perception of whole-body linear oscillation. Exp Brain Res 1986a;64(2):264-71. PMID 3492383
16: Benson AJ, Vieville T. European vestibular experiments on the Spacelab-1 mission: 6. Yaw axis vestibulo-ocular reflex. Exp Brain Res 1986b;64(2):279-83. PMID 3803473
17: Berthoz A, Brandt T, Dichgans J, Probst T, Bruzek W, Viéville T. European vestibular experiments on the Spacelab-1 mission: 5. Contribution of the otoliths to the vertical vestibulo-ocular reflex. Exp Brain Res 1986;64(2):272-8. PMID 3803472
18: Bertolini G, Durmaz MA, Ferrari K, Küffer A, Lambert C, Straumann D. Determinants of motion sickness in tilting trains: coriolis/cross-coupling stimuli and tilt delay. Front Neurol 2017;8:195. PMID 28555125
19: Besnard S, Bois J, Hitier M, Vogt J, Laforet P, Golding JF. Motion sickness lessons from the Southern Ocean. Aerosp Med Hum Perform 2021;92(9):720-7. PMID 34645552
20: Bonato F, Bubka A, Thornton W. Visual blur and motion sickness in an optokinetic drum. Aerosp Med Hum Perform 2015;86(5):440-4. PMID 25945660
21: Borison HL, Borison R. Motion sickness reflex arc bypasses the area postrema in cats. Exp Neurol 1986;92:723-37. PMID 3709744
22: Borison HL, Wang SC. Functional localization of central coordinating mechanisms for emesis in cat. J Neurophysiol 1949;12:305-13. PMID 18137708
23: Bos JE, Bles W. Motion sickness induced by optokinetic drums. Aviat Space Environ Med 2004;75:172-4. PMID 14960055
24: Bowins B. Motion sickness: a negative reinforcement model. Brain Res Bull 2010;81:7-11. PMID 19808080
25: Boyle R. Otolith adaptive responses to altered gravity. Neurosci Biobehav Rev 2021;122:218-28. PMID 33152424
26: Brandt T, Bauer M, Benson J, Huppert D. Motion sickness in ancient China: seasickness and cart-sickness. Neurology 2016;87(3):331-5. PMID 27432177
27: Brandt U. The cause and practical importance of oculogravic illusions. Acta Otolaryngol 1962;54:127-35. PMID 13872519
28: Bridgeman B, Blaesi S, Campusano R. Optical correction reduces simulator sickness in a driving environment. Hum Factors 2014;56(8):1472-81. PMID 25509825
29: Bronstein AM, Golding JF, Gresty MA. Visual vertigo, motion sickness, and disorientation in vehicles. Semin Neurol 2020;40(1):116-29. PMID 32045940
30: Brooks JO, Goodenough RR, Crisler MC, et al. Simulator sickness during driving simulation studies. Accid Anal Prev 2010;42(3):788-96. PMID 20380904
31: Bubka A, Bonato F. Optokinetic drum tilt hastens the onset of vection-induced motion sickness. Aviat Space Environ Med 2003;74:315-9. PMID 12688448
32: Busoni P, Sarti A, Crescioli M, Agostino MR, Sestini G, Banti S. Motion sickness and postoperative vomiting in children. Paediatr Anaesth 2002;12:65-8. PMID 11849578
33: Chang CH, Stoffregen TA, Tseng LY, Lei MK, Cheng KB. Control of a virtual vehicle influences postural activity and motion sickness in pre-adolescent children. Hum Mov Sci 2021;78:102832. PMID 34157576
34: Chen W, Chao JG, Wang JK, Chen XW, Tan C. Subjective vertical conflict theory and space motion sickness. Aerosp Med Hum Perform 2016;87(2):128-36. PMID 26802378
35: Cheung BS, Howard IP, Money KE. Visually-induced sickness in normal and bilaterally labyrinthine-defective subjects. Aviat Space Environ Med 1991;62:527-31. PMID 1859339
36: Clark B, Graybiel A. Contributing factors in the perception of the oculogravic illusion. Am J Psychol 1963;76:18-27. PMID 14021494
37: Clark B, Graybiel A. Factors contributing to the delay in the perception of the oculogravic illusion. Am J Psychol 1966;79(3):377-88. PMID 5968474
38: Clark B, Graybiel A. Influence of contact cues on the perception of the oculogravic illusion. Acta Otolaryngol 1968;65(4):373-80. PMID 5654494
39: Clarke AH, Scherer H. Caloric testing of the vestibular function during orbital flight. Adv Otorhinolaryngol 1988;42:31-5. PMID 3265018
40: Clarke AH, Scherer H, Schleibinger J. Body position and caloric nystagmus response. Acta Otolaryngol 1988;106(5-6):339-47. PMID 3207001
41: Coats AC, Smith SY. Body position and the intensity of caloric nystagmus. Acta Otolaryngol 1967;63(6):515-32.** PMID 6037902
42: Cohen B, Dai M, Raphan T. The critical role of velocity storage in production of motion sickness. Ann N Y Acad Sci 2003;1004:359-76. PMID 14662476
43: Cohen B, Dai M, Yakushin SB, Cho C. The neural basis of motion sickness. J Neurophysiol 2019;121(3):973-82. PMID 30699041
44: Curthoys IS. The delay of the oculogravic illusion. Brain Res Bull 1996;40(5-6):407-10. PMID 8886366
45: Dai M, Kunin M, Raphan T, Cohen B. The relation of motion sickness to the spatial-temporal properties of velocity storage. Exp Brain Res 2003;151:173-89. PMID 12783152
46: Dai M, Sofroniou S, Kunin M, Raphan T, Cohen B. Motion sickness induced by off-vertical axis rotation (OVAR). Exp Brain Res 2010;204(2):207-22. PMID 20535456
47: D’Amour S, Bos JE, Keshavarz B. The efficacy of airflow and seat vibration on reducing visually induced motion sickness. Exp Brain Res 2017;235(9):2811-20. PMID 28634889
48: Dida M, Cian C, Barraud PA, Guerraz M, Laboissière R. Idiosyncratic multisensory reweighting as the common cause for motion sickness susceptibility and adaptation to postural perturbation. PLoS One 2021;16(12):e0260863. PMID 34882734
49: Dobie T, McBride D, Dobie T Jr, May J. The effects of age and sex on susceptibility to motion sickness. Aviat Space Environ Med 2001;72:13-20. PMID 11194988
50: Dye L. Lawmaker did what was expected of him--got sick: he prefers space to Senate, Garn admits. Los Angeles Times. April 19, 1985.
51: Feinle C, Grundy D, Read NW. Fat increases vection-induced nausea independent of changes in gastric emptying. Physiol Behav 1995;58:1159-65. PMID 8623015
52: Furman JM, Marcus DA, Balaban CD. Rizatriptan reduces vestibular-induced motion sickness in migraineurs. J Headache Pain 2011;12(1):81-8. PMID 20862509
53: Gahlinger PM. Cabin location and the likelihood of motion sickness in cruise ship passengers. J Travel Med 2000;7:120-4. PMID 11179940
54: Gerathewohl SJ. Otolith functions in weightlessness. Life Sci Space Res 1975;13:33-40. PMID 11913428
55: Golding JF, Doolan K, Acharya A, Tribak M, Gresty MA. Cognitive cues and visually induced motion sickness. Aviat Space Environ Med 2012;83(5):477-82. PMID 22606863
56: Golding JF, Gresty MA. Pathophysiology and treatment of motion sickness. Curr Opin Neurol 2015;28(1):83-8. PMID 25502048
57: Golding JF, Paillard AC, Normand H, Besnard S, Denise P. Prevalence, predictors, and prevention of motion sickness in zero-g parabolic flights. Aerosp Med Hum Perform 2017;88(1):3-9. PMID 28061915
58: Golding JF, Stott JR. Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate. Br J Clin Pharmacol 1997;43:633-7. PMID 9205824
59: Gordon CR, Spitzer O, Doweck I, Shupak A, Gadoth N. The vestibule-ocular reflex and seasickness susceptibility. J Vestib Res 1996;6:229-33. PMID 8839819
60: Graybiel A. Oculogravic illusion. AMA Arch Ophthalmol 1952;48(5):605-15. PMID 12984891
61: Graybiel A. Susceptibility to acute motion sickness in blind persons. Aerospace Med 1970;41:650-3. PMID 5446920
62: Graybiel A, Clark B. Duration of oculogyral illusion as a function of the interval between angular acceleration and deceleration; its significance in terms of dynamics of semicircular canals in man. J Appl Physiol 1952;5(4):147-52. PMID 129996748
63: Graybiel A, Johnson WH, Money KE, Malcolm RE, Jennings GL. Oculogravic illusion in response to straight-ahead acceleration of CF-104 aircraft. Aviat Space Environ Med 1979;50(4):382-6. PMID 464960
64: Graybiel A, Knepton J. Sopite syndrome: a sometimes sole manifestation of motion sickness. Aviat Space Environ Med 1976;47:873-82. PMID 949309
65: Graybiel A, Miller EF 2nd, Newsom BD, Kennedy RS. The effect of water immersion on perception of the oculogravic illusion in normal and labyrinthine-defective subjects. Acta Otolaryngol 1968;65(6):599-610. PMID 5706030
66: Grohmann R. Critical remarks on the interpretation of the thermal reaction of the labyrinth to weightlessness and evidence for the validity of the extended Bárány theory. [Article in German] HNO 1986;34(1):40-5. PMID 3949550
67: Grunfeld E, Gresty MA. Relationship between motion sickness, migraine and menstruation in crew members of a “round the world” yacht race. Brain Res Bull 1998;47:433-6. PMID 10052571
68: Grunfeld EA, Price C, Goadsby PJ, Gresty MA. Motion sickness, migraine, and menstruation in mariners. Lancet 1998;351:1106. PMID 9660592
69: Hain TC, Hanna PA, Rheinberger MA. Mal de debarquement. Arch Otolaryngol Head Neck Surg 1999;125:615-20. PMID 10367916
70: Harada T, Sugawara T, Ito T, et al. Vestibular morphological asymmetry associated with motion sickness susceptibility. Front Neurosci 2021;15:763040. PMID 34803595
71: Hasler WL, Kim MS, Chey WD, Stevenson V, Stein B, Owyang C. Central cholinergic and alpha-adrenergic mediation of gastric slow wave dysrhythmias evoked during motion sickness. Am J Physiol 1995;268:G539-47. PMID 7733281
72: Hausler R. Ski sickness. Acta Otolaryngol 1995;115:1-2. PMID 7762376
73: Henriques IF, Douglas de Oliveira DW, Oliveira-Ferreira F, Andrade PM. Motion sickness prevalence in school children. Eur J Pediatr 2014;173(11):1473-82. PMID 24893949
74: Hill J. The care of the sea-sick. Brit Med J 1936;2:802-7. PMID 20780192
75: Hoffer ME, Gottshall K, Kopke RD, et al. Vestibular testing abnormalities in individuals with motion sickness. Otol Neurotol 2003;24:633-6. PMID 12851557
76: Horing B, Weimer K, Schrade D, et al. Reduction of motion sickness with an enhanced placebo instruction: an experimental study with healthy participants. Psychosom Med 2013;75(5):497-504. PMID 23697466
77: Hotovy H. How 11 deaf men helped shape NASA's human spaceflight program. Available at: https://www.nasa.gov/feature/how-11-deaf-men-helped-shape-nasas-human-spaceflight-program. Accessed August 2022.
78: Hoyt RE, Lawson BD, McGee HA, Strompolis ML, McClellan MA. Modafinil as a potential motion sickness countermeasure. Aviat Space Environ Med 2009;80(8):709-15. PMID 19653573
79: Hu S, Glaser KM, Hoffman TS, Stanton TM, Gruber MB. Motion sickness susceptibility to optokinetic rotation correlates to past history of motion sickness. Aviat Space Environ Med 1996;67:320-4. PMID 8900982
80: Hu S, McChesney KA, Player KA, Bahl AM, Buchanan JB, Scozzafava JE. Systematic investigation of physiological correlates of motion sickness induced by viewing an optokinetic rotating drum. Aviat Space Environ Med 1999;70:759-65. PMID 10447048
81: Hu S, Stern RM. The retention of adaptation to motion sickness eliciting stimulation. Aviat Space Environ Med 1999;70:766-8. PMID 10447049
82: Huang KC, John AR, Jung TP, Tsai WF, Yu YH, Lin CT. comparing the differences in brain activities and neural comodulations associated with motion sickness between drivers and passengers. IEEE Trans Neural Syst Rehabil Eng 2021;29:1259-67. PMID 34181544
83: Huppert D, Benson J, Brandt T. A historical view of motion sickness-a plague at sea and on land, also with military impact. Front Neurol 2017;8:114. PMID 28421029
84: Huppert D, Grill E, Brandt T. Survey of motion sickness susceptibility in children and adolescents aged 3 months to 18 years. J Neurol 2019;266(Suppl 1):65-73. PMID 31087161
85: Irwin JA. The pathology of sea-sickness. Lancet 1881;2:907-9.
86: Ishak S, Bubka A, Bonato F. Visual occlusion decreases motion sickness in a flight simulator. Perception 2018;47(5):521-30. PMID 29490570
87: James W. The sense of dizziness in deaf-mutes. Am J Otol 1882;4:239-54.
88: Jokerst MD, Gatto M, Fazio R, Gianaros PJ, Stern RM, Koch KL. Effects of gender of subjects and experimenter on susceptibility to motion sickness. Aviat Space Environ Med 1999a;70:962-5. PMID 10519473
89: Jokerst MD, Gatto M, Fazio R, Stern RM, Kock KL. Slow deep breathing prevents the development of tachygastria and symptoms of motion sickness. Aviat Space Environ Med 1999b;70:1189-92. PMID 10596772
90: Jones GM. Origin significance and amelioration of Coriolis illusions from the semicircular canals: a non-mathematical appraisal. Aerospace Med 1970;41:483-90. PMID 5430674
91: Kaplan J, Ventura J, Bakshi A, Pierobon A, Lackner JR, DiZio P. The influence of sleep deprivation and oscillating motion on sleepiness, motion sickness, and cognitive and motor performance. Auton Neurosci 2017;202:86-96. PMID 27641791
92: Karrim N, Byrne R, Magula N, Saman Y. Antihistamines for motion sickness. Cochrane Database Syst Rev 2022;10(10):CD012715. PMID 36250781
93: Kass J, von Baumgarten R, Benson A, et al. The European vestibular experiments in Spacelab-1. Adv Space Res 1984;4(10):3-9. PMID 11539641
94: Kass JR, Bruzek W, Probst T, Thümler R, Vieville T, Vogel H. European vestibular experiments on the Spacelab-1 mission: 2. Experimental equipment and methods. Exp Brain Res 1986;64(2):247-54. PMID 3492381
95: Kaufeld M, De Coninck K, Schmidt J, Hecht H. Chewing gum reduces visually induced motion sickness. Exp Brain Res 2022;240(2):651-63. PMID 34997261
96: Kennedy RS, Graybiel A, McDonough RC, Beckwith FD. Symptomatology under storm conditions in the North Atlantic in control subjects and in persons with bilateral labyrinthine defects. Acta Otolaryngol 1968;66:533-40. PMID 5732654
97: Keshavarz B, Adams MS, Gabriel G, Sergio LE, Campos JL. Concussion can increase the risk of visually induced motion sickness. Neurosci Lett 2024;830:137767. PMID 38599370
98: Keshavarz B, Golding JF. Motion sickness: current concepts and management. Curr Opin Neurol 2022;35(1):107-112. PMID 34839340
99: Kim MS, Chey WD, Owyang C, Hasler WL. Role of plasma vasopressin as a mediator of nausea and gastric slow wave dysrhythmias in motion sickness. Am J Physiol 1997;272:G853-62. PMID 9142918
100: Kiniorski ET, Weider SK, Finley JR, et al. Sopite symptoms in the optokinetic drum. Aviat Space Environ Med 2004;75:872-5. PMID 15497367
101: Kluger J. Low point: Senator Jake Garn flies in space. Available at: http://content.time.com/time/specials/2007/article/0,28804,1664897_1664899_1666145,00.html. Accessed August 2022.
102: Kuritzky A, Seigler DK, Hassanien R. Vertigo, motion sickness and migraine. Headache 1981;21:227-31. PMID 7287423
103: Lackner JR, DiZio P. Audiogravic and oculogravic illusions represent a unified spatial remapping. Exp Brain Res 2010;202(2):513-8. PMID 20062982
104: Lanska DJ. William Hyde Wollaston. In: Aminoff MJ, Daroff RB, editors. Encyclopedia of the neurological sciences. 2nd edition. Oxford: Academic Press/Elsevier, 2014a;4:777-8.
105: Lanska DJ. William James. In: Aminoff MJ, Daroff RB, editors. Encyclopedia of the neurological sciences. 2nd edition. Oxford: Academic Press/Elsevier, 2014b;2:771-3.
106: Lanska DJ, Sommer BW. Interview with Robert B Daroff MD. American Academy of Neurology Oral History Project: February 22, 2014. Minneapolis, MN: American Academy of Neurology, 2014.
107: Lee MD. The caloric test in the supine and prone positions. J Laryngol Otol 1969;83(8):797-801. PMID 5802188
108: Lee SH, Jeong SH, Kim JS, et al. Effect of prophylactic medication on associated dizziness and motion sickness in migraine. Otol Neurotol 2018;39(1):e45-e51. PMID 29227453
109: Leigh RJ, Daroff RB. Space motion sickness: etiological hypothesis and a proposal for diagnostic clinical examination. Aviat Space Environ Med 1985;56:469-73. PMID 3924014
110: Leung AK, Hon KL. Motion sickness: an overview. Drugs Context 2019;8:2019-9-4. PMID 32158479
111: Levine ME, Muth ER, Williamson MJ, Stern RM. Protein-predominant meals inhibit the development of gastric tachyarrhythmia, nausea and the symptoms of motion sickness. Aliment Pharmacol Ther 2004;19:583-90. PMID 14987327
112: Lien HC, Sun WM, Chen YH, Kim H, Hasler W, Owyang C. Effects of ginger on motion sickness and gastric slow-wave dysrhythmias induced by circular vection. Am J Physiol Gastrointest Liver Physiol 2003;284:G481-9. PMID 12576305
113: Lin YG, Chen PH, Chang FY, Wu LT, Liao KY, Wu TC. Delirium due to scopolamine patch in a 4-year-old boy. J Formos Med Assoc 2011;110(3):208-11. PMID 21497284
114: Lindseth G, Lindseth PD. The relationship of diet to airsickness. Aviat Space Environ Med 1995;66:537-41. PMID 7646403
115: Lisberger SG, Fuchs AF. Role of primate flocculus during rapid behavioral modification of vestibulo-ocular reflex. J Neurophysiol 1978;41:733-63. PMID 96225
116: Lyons RD. Animals upstage astronaut crew. New York Times. May 2, 1985a.
117: Lyons RD. One thing NASA can't settle: astronauts' stomachs. New York Times. May 5, 1985b.
118: Mair IW. The mal de debarquement syndrome. J Audiol Med 1996;5:21-5.
119: Mallinson AL, Longridge NS. Motion sickness and vestibular hypersensitivity. J Otolaryngol 2002;31:381-5. PMID 12593552
120: Matsangas P, McCauley ME. Yawning as a behavioral marker of mild motion sickness and sopite syndrome. Aviat Space Environ Med 2014;85(6):658-61. PMID 24919388
121: Matsangas P, McCauley ME, Becker W. The effect of mild motion sickness and sopite syndrome on multitasking cognitive performance. Hum Factors 2014;56(6):1124-35. PMID 25277021
122: McNally WJ, Stuart EA, Jamieson JS, Gaulton G. Some experiments with caloric stimulation of the human labyrinth to study the relative values of ampullo-petal and ampullo-fugal endolymphatic flow (Ewald's law). Trans Am Acad Ophthal Otolaryng 1947;52:513-7.
123: Meng D, Zhou X, Hu T, et al. Study of clinical correlation of motion sickness in patients with vestibular migraine. Front Neurosci 2022;16:986860. PMID 36203809
124: Miller AD, Wilson VJ. “Vomiting center” reanalyzed: an electrical stimulation study. Brain Res 1983;270:154-8. PMID 6347342
125: Mo FF, Qin HH, Wang XL, Shen ZL, et al. Acute hyperglycemia is related to gastrointestinal symptoms in motion sickness: an experimental study. Physiol Behav 2012;105(2):394-401. PMID 21907224
126: Money KE. Motion sickness. Physiol Rev 1970;50:1-39. PMID 4904269
127: Morales MF. Asynchrony of labyrinthine receptors as physical factor in motion sickness. Bull Math Biophys 1946;8:147-57. PMID 20283555
128: Murdin L, Golding J, Bronstein A. Managing motion sickness. BMJ 2011;343:d7430. PMID 22138695
129: Muth ER, Jokerst M, Stern RM, Koch KL. Effect of dimenhydrinate on gastric tachyarrhythmia and symptoms of vection-induced motion sickness. Aviat Space Environ Med 1995;66:1041-5. PMID 8588792
130: Muth ER, Stern RM, Koch KL. Effects of vection-induced motion sickness on gastric myoelectric activity and oral-cecal transit time. Dig Dis Sci 1996;41:330-4. PMID 8601378
131: Nachum Z, Gordon CR, Shahal B, Spitzer O, Shupak A. Active high-frequency vestibule-ocular reflex and seasickness susceptibility. Laryngoscope 2002;112:179-82. PMID 11802059
132: Nooij SAE, Bockisch CJ, Bülthoff HH, Straumann D. Beyond sensory conflict: The role of beliefs and perception in motion sickness. PLoS One 2021;16(1):e0245295. PMID 33465124
133: Nunes CP, Rodrigues CC, Cardoso CAF, et al. Clinical evaluation of the use of ginger extract in the preventive management of motion sickness. Curr Ther Res Clin Exp 2020;92:100591. PMID 32714473
134: Oman CM. Motion sickness: a synthesis and evaluation of the sensory conflict theory. Can J Physiol Pharmacol 1990;68:294-303. PMID 2178753
135: Owen N, Leadbetter AG, Yardley L. Relationship between postural control and motion sickness in healthy subjects. Brain Res Bull 1998;47:471-4. PMID 10052576
136: Paige GD. Caloric responses after horizontal canal inactivation. Acta Otolaryngol 1985;100(5-6):321-7.** PMID 4082971
137: Park AH, Hu S. Gender differences in motion sickness history and susceptibility to optokinetic rotation-induced motion sickness. Aviat Space Environ Med 1999;70:1077-80. PMID 10608604
138: Peddareddygari LR, Kramer PD, Hanna PA, Levenstien MA, Grewal RP. Genetic analysis of a large family with migraine, vertigo, and motion sickness. Can J Neurol Sci 2019;46(5):512-7. PMID 31258098
139: Perrin P, Lion A, Bosser G, Gauchard G, Meistelman C. Motion sickness in rally car co-drivers. Aviat Space Environ Med 2013;84(5):473-7. PMID 23713212
140: Qi R, Su Y, Pan L, et al. Anti-cholinergics mecamylamine and scopolamine alleviate motion sickness-induced gastrointestinal symptoms through both peripheral and central actions. Neuropharmacology 2019;146:252-63. PMID 30543811
141: Quarck G, Etard O, Darlot C, Denise P. Motion sickness susceptibility correlates with otolith- and canal-ocular reflexes. NeuroReport 1998;9:2253-6. PMID 9694209
142: Reason JT. Motion sickness adaptation: a neural mismatch model. J R Soc Med 1978;71:819-29. PMID 731645
143: Reason JT, Brand JJ. Motion sickness. London: Academic Press, 1975.
144: Reason J, Graybiel A. Factors contributing to motion sickness susceptibility: adaptability and receptivity. In: Predictability of motion sickness in the selection of pilots. AGARD Conference Proceedings 109. Neuilly-sur-Seine, France: Advisory Group for Aerospace Research and Development, North Atlantic Treaty Organization, 1973;Paper B4:1-15.
145: Reid K, Grundy D, Khan MI, Read NW. Gastric emptying and the symptoms of vection-induced nausea. Eur J Gastroenterol Hepatol 1995;7:103-8. PMID 7712299
146: Reschke MF, Krnavek JM, Somers JT, Ford G. A brief history of space flight with a comprehensive compendium of vestibular and sensorimotor research conducted across the various flight programs. NASA/SP-2007-560. NASA, 2007.
147: Reschke MF, Wood SJ, Clément GR. A case study of severe space motion sickness. Aerosp Med Hum Perform 2018;89(8):749-53. PMID 30020061
148: Riccio GE, Stoffregen TA. An ecological theory of motion sickness and postural instability. Ecol Psychol 1991;3:195-240. PMID 3281178
149: Roberts DC, Marcelli V, Gillen JS, Carey JP, Della Santina CC, Zee DS. MRI magnetic field stimulates rotational sensors of the brain. Curr Biol 2011;21(19):1635-40.** PMID 21945276
150: Robinson DA. Adaptive gain control of the vesibulo-ocular reflex by the cerebellum. J Neurophysiol 1976;39:954-69. PMID 1086347
151: Russell ME, Hoffman B, Stromberg S, Carlson CR. Use of controlled diaphragmatic breathing for the management of motion sickness in a virtual reality environment. Appl Psychophysiol Biofeedback 2014;39(3-4):269-77. PMID 25280524
152: Russomano T, da Rosa M, Dos Santos MA. Space motion sickness: a common neurovestibular dysfunction in microgravity. Neurol India 2019;67(Supplement):S214-8. PMID 31134912
153: Sakai H, Harada T, Larroque SK, et al. Left parietal involvement in motion sickness susceptibility revealed by multimodal magnetic resonance imaging. Hum Brain Mapp 2022;43(3):1103-11. PMID 34783415
154: Salter S, Diels C, Herriotts P, Kanarachos S, Thake D. Motion sickness in automated vehicles with forward and rearward facing seating orientations. Appl Ergon 2019;78:54-61. PMID 31046959
155: Scherer H. Thermal reaction in weightlessness in outer space. Observations on Robert Báránys' theory. [Article in German] Arch Otorhinolaryngol Suppl 1984a;2 Suppl:1-16. PMID 6336030
156: Scherer H. Thermal reaction of the labyrinth in weightlessness in space. Reflections on the theory of Bárány. [Article in German] Arch Otorhinolaryngol Suppl 1984b;2:27-46. PMID 6596922
157: Scherer H, Brandt U, Clarke AH, Merbold U, Parker R. European vestibular experiments on the Spacelab-1 mission: 3. Caloric nystagmus in microgravity. Exp Brain Res 1986;64(2):255-63. PMID 3492382
158: Scherer H, Clarke AH. The caloric vestibular reaction in space. Physiological considerations. Acta Otolaryngol 1985;100(5-6):328-36. PMID 4082972
159: Scherer H, Clarke AH. Thermal stimulation of the vestibular labyrinth during orbital flight. Arch Otorhinolaryngol 1987;244(3):159-66. PMID 3499885
160: Schmal F. Neuronal mechanisms and the treatment of motion sickness. Pharmacology 2013;91(3-4):229-41. PMID 23615033
161: Shupak A, Gordon CR. Motion sickness: advances in pathogenesis, prediction, prevention, and treatment. Aviat Space Environ Med 2006;77:1213-23. PMID 17183916
162: Siddiqi AA. Challenge to Apollo: The Soviet Union and the Space Race, 1945-1974 (NASA SP-2000-4408). Washington, DC: NASA History Division, National Aeronautics and Space Administration, 2000.
163: Simmons RG, Phillips JB, Lojewski RA, Wang Z, Boyd JL, Putcha L. The efficacy of low-dose intranasal scopolamine for motion sickness. Aviat Space Environ Med 2010;81:405-12. PMID 20377145
164: Solimini AG. Are there side effects to watching 3D movies. A prospective crossover observational study on visually induced motion sickness. PLoS One 2013;8(2):e56160. PMID 23418530
165: Spiegel EA, Sokalchuk A. Motion sickness. In: Glasser O, editor. Medical physics, Vol. 2. Chicago: Year Book Publishers, 1950:572-80.
166: Spinks A, Wasiak J. Scopolamine (hyoscine) for preventing and treating motion sickness. Cochrane Database Syst Rev 2011;(6):CD002851. PMID 21678338
167: Stahle J. Controversies on the caloric response. From Bárány's theory to studies in microgravity. Acta Otolaryngol 1990;109(3-4):162-7.** PMID 2180248
168: Stankovic AS, Alvarenga DL, Coleman Daniels VR, Simmons RG, Buckey JC, Putcha L. Intranasal scopolamine for motion sickness. Aerosp Med Hum Perform 2019;90(11):917-24. PMID 31666152
169: Stern RM, Hu S, Uijtdejaage SHJ, Muth ER, Xu LH, Koch KL. Asian hypersusceptibility to motion sickness. Hum Hered 1996;46:7-14. PMID 8825456
170: Stern RM, Kock KL, Leibowitz HW, Lindblad MS, Shupert Cl, Stewart WR. Tachygastria and motion sickness. Aviat Space Environ Med 1985;56:1074-7. PMID 4074260
171: Stevenson RE. Oral history 2 transcript. Robert E Stevenson interviewed by Carol Butler. Houston, Texas - 13 May 1999. NASA Johnson Space Center Oral History Project. NASA/Johnson Space Center, 1999. Available at: https://historycollection.jsc.nasa.gov/JSCHistoryPortal/history/oral_histories/StevensonRE/RES_5-13-99.pdf. Accessed August 2022.
172: Stoffregen TA, Smart LJ Jr. Postural instability precedes motion sickness. Brain Res Bull 1998;47:437-48. PMID 10052572
173: Stromberg SE, Russell ME, Carlson CR. Diaphragmatic breathing and its effectiveness for the management of motion sickness. Aerosp Med Hum Perform 2015;86(5):452-7. PMID 25945662
174: Suzuki M, Kadir A, Hayashi N, Takamoto M. Direct influence of temperature on the semicircular canal receptor. J Vestib Res 1998;8(2):169-73. PMID 9547491
175: Takeda N, Morita M, Horii A, Nishiike S, Kitahara T, Uno A. Neural mechanisms of motion sickness. J Med Invest 2001;48:44-59. PMID 11286016
176: Takov V, Tadi P. Motion sickness. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2022. PMID 30969528
177: Thornton WE, Bonato F. Space motion sickness and motion sickness: symptoms and etiology. Aviat Space Environ Med 2013;84(7):716-21. PMID 23855067
178: Turner M, Griffin MJ. Motion sickness incidence during a round-the-world yacht race. Aviat Space Environ Med 1995;66:849-56. PMID 7487823
179: Turner M, Griffin MJ. Motion sickness in public road transport: passenger behavior and susceptibility. Ergonomics 1999a;42:444-61. PMID 10048305
180: Turner M, Griffin MJ. Motion sickness in public road transport: the relative importance of motion, vision and individual differences. Brit J Psychol 1999b;90:519-30. PMID 10629944
181: Valli P, Buizza A, Botta L, Zucca G, Ghezzi L, Valli S. Convection, buoyancy or endolymph expansion: what is the actual mechanism responsible for the caloric response of semicircular canals? J Vestib Res 2002;12(4):155-65. PMID 12897398
182: Vogel H, Kass JR. European vestibular experiments on the Spacelab-1 mission: 7. Ocular counterrolling measurements pre- and post-flight. Exp Brain Res 1986;64(2):284-90. PMID 3803474
183: von Baumgarten RJ. European vestibular experiments on the Spacelab-1 mission: 1. Overview. Exp Brain Res 1986;64(2):239-46. PMID 3492380
184: von Baumgarten RJ, Baldrighi G, Shillinger GL Jr, Harth O, Thuemler R. Vestibular function in the space environment. Acta Astronaut 1975;2(1-2):49-58. PMID 11841094
185: Von Holst E. Relations between the central nervous system and the peripheral organs. Br J Animal Behavior 1954;2:94-8.
186: Wada T, Yoshida K. Effect of passengers' active head tilt and opening/closure of eyes on motion sickness in lateral acceleration environment of cars. Ergonomics 2016;59(8):1050-9. PMID 26481809
187: Wang J, Lewis RF. Contribution of intravestibular sensory conflict to motion sickness and dizziness in migraine disorders. J Neurophysiol 2016;116(4):1586-91. PMID 27385797
188: Warwick-Evans LA, Symons N, Fitch T, Burrows L. Evaluating sensory conflict and postural instability. Theories of motion sickness. Brain Res Bull 1998;47:465-9. PMID 10052575
189: Weech S, Moon J, Troje NF. Influence of bone-conducted vibration on simulator sickness in virtual reality. PLoS One 2018;13(3):e0194137. PMID 29590147
190: Weerts AP, Vanspauwen R, Fransen E, Jorens PG, Van de Heyning PH, Wuyts FL. Space motion sickness countermeasures: a pharmacological double-blind, placebo-controlled study. Aviat Space Environ Med 2014;85(6):638-44. PMID 24919385
191: Wei Y, Zheng J, So RHY. Allocating less attention to central vision during vection is correlated with less motion sickness. Ergonomics 2018;61(7):933-46. PMID 29325490
192: Wolfe JW. Evidence for control of nystagmic habituation by folium-tuber vermis and fastigial nuclei. Acta Otolaryngol 1968;Suppl 231:1-48. PMID 5656196
193: Wollaston W. The Croonian Lecture. Philos Trans R Soc Lond 1810;100:1-15.
194: Wood CD, Graybiel A. A theory of motion sickness based on pharmacological reactions. Clin Pharmacol Ther 1970;11:621-9. PMID 5455629
195: Wood CD, Stewart JJ, Wood MJ, et al. Habituation and motion sickness. J Clin Pharmacol 1994;34:628-34. PMID 8083394
196: Wurthmann S, Naegel S, Roesner M, et al. Sensitized rotatory motion perception and increased susceptibility to motion sickness in vestibular migraine: a cross-sectional study. Eur J Neurol 2021;28(7):2357-66. PMID 33914990
197: Xu LH, Yang Y, Liu HX, et al. Inner ear arginine vasopressin-vasopressin receptor 2-aquaporin 2 signaling pathway is involved in the induction of motion sickness. J Pharmacol Exp Ther 2020;373(2):248-60. PMID 32165443
198: Yen Pik Sang FD, Billar JP, Golding JF, Gresty MA. Behavioral methods of alleviating motion sickness: effectiveness of controlled breathing and a music audiotape. J Travel Med 2003a;10:108-11. PMID 12650654
199: Yen Pik Sang FD, Golding JF, Gresty MA. Suppression of sickness by controlled breathing during mildly nauseogenic motion. Aviat Space Environ Med 2003b;74:998-1002. PMID 14503682
200: Young IM, Lowry LD. Mechanics of caloric stimulation in a case with a plug in the horizontal semicircular canal. Yonsei Med J 1994;35(1):84-90. PMID 8009901
201: Zenner HP, Zimmermann U. Caloric evoked motile responses of mammalian vestibular sensory cells. Acta Otolaryngol 1995;115(4):484-7. PMID 7572121
202: Zhang LL, Liu HQ, Yu XH, et al. The combination of scopolamine and psychostimulants for the prevention of severe motion sickness. CNS Neurosci Ther 2016;22(8):715-22. PMID 27160425
203: Zhao Q, Ning BF, Zhou JY, et al. Transcutaneous electrical acustimulation ameliorates motion sickness induced by rotary chair in healthy subjects: a prospective randomized crossover study. Neuromodulation 2022;25(8):1421-30. PMID 35088725

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Motion sickness

Differential Diagnosis

mal de debarquement

Also Relevant

Mal de debarquement
Nausea and vomiting
Pathologic yawning
Phenytoin
Vestibular migraine

Clinical Categories

Patient Handouts

Balance disorders

Web References

Clinical Trials

FDA: Motion Sickness

Motion sickness

Motion sickness

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Biological basis

Anatomic localization

Pathophysiology

Space sickness (space adaptation syndrome)

Epidemiology

Differential diagnosis

Confusing conditions

Diagnostic workup

Management

Table 1. Anti-Motion Sickness Drugs Available in the United States

Media

References

Contributors

Author

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

NF2-related schwannomatosis

Neurogenetics and genetic and genomic testing

Acute traumatic spinal cord injury

Tumors of the skull base

Common maculopathies

Toxic and nutritional deficiency optic neuropathies

Nystagmus

Third nerve palsy

	• Motion sickness susceptibility from infancy to adolescence follows an inverse U-shaped curve with three phases that may be related to the visual-vestibular mismatch theory.
	• Motion sickness susceptibility is low in the first year of life, increases to a prepubertal peak, and declines after puberty.

Motion sickness

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Biological basis

Anatomic localization

Pathophysiology

Space sickness (space adaptation syndrome)

Epidemiology

Differential diagnosis

Confusing conditions

Diagnostic workup

Management

Table 1. Anti-Motion Sickness Drugs Available in the United States

Media

References

Contributors

Author

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

NF2-related schwannomatosis

Neurogenetics and genetic and genomic testing

Acute traumatic spinal cord injury

Tumors of the skull base

Common maculopathies

Toxic and nutritional deficiency optic neuropathies

Nystagmus

Third nerve palsy

This is an article preview.
Start a Free Account
to access the full version.